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ABSTRACT 
 
The G1 Cyclin Cln3p Regulates Vacuole Homeostasis through Phosphorylation of a 
Scaffold Protein, Bem1p, in Saccharomyces cerevisiae. (December 2005) 
Bong Kwan Han, B.S., Seoul National University; 
M.S., Korea Advanced Institute of Science and Technology 
Chair of Advisory Committee: Dr. Michael Polymenis 
 
 
How proliferating cells maintain the copy number and overall size of their organelles is 
not clear. In the budding yeast Saccharomyces cerevisiae the G1 cyclins Cln1,2,3p 
control initiation of cell division by regulating the activity of the cyclin-dependent 
kinase (Cdk) Cdc28p. We show that Cln3p controls vacuolar (lysosomal) biogenesis and 
segregation. First, loss of Cln3p, but not Cln1p or Cln2p, resulted in vacuolar 
fragmentation. Although the vacuoles of cln3Δ cells were fragmented, together they 
occupied a large space, which accounted for a significant fraction of the overall cell size 
increase in cln3Δ cells. Second, cytosol prepared from cells lacking Cln3p had reduced 
vacuolar homotypic fusion activity in cell-free assays. Third, vacuolar segregation was 
perturbed in cln3Δ cells. Our findings reveal a novel role for a eukaryotic G1 cyclin in 
cytoplasmic organelle biogenesis and segregation. 
Furthermore we show that the scaffold protein Bem1p, a critical regulator of 
Cdc42p activity, is a downstream effector of Cln3p/Cdc28p complex. The Cdc42p 
GTPase is known to be required for vacuole fusion. Our results suggest that Ser72 on 
Bem1p is phosphorylated by Cdc28p in a Cln3p-dependent manner to promote vacuole 
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fusion. Replacing Ser72 with Asp, to mimic phosphorylation at an optimal Cdk-
consensus site located in the first SH3 domain of Bem1p, suppressed vacuolar 
fragmentation in cells lacking Cln3p. Using in vivo and in vitro assays, we found that 
Cln3p was unable to promote vacuole fusion in the absence of Bem1p or in the presence 
of a non-phosphorylatable Bem1p-Ser72Ala mutant. Furthermore, activation of Cdc42p 
also suppressed vacuolar fragmentation in the absence of Cln3p. Our results provide a 
mechanism that links cyclin-dependent kinase activity with vacuole fusion through 
Bem1p and the Cdc42p GTPase cycle. 
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CHAPTER I 
INTRODUCTION 
 
The cell cycle 
 
The mitotic cell cycle of eukaryotic cells is divided into four distinct phases; G1, S, G2 
and M phase. S phase is a period when DNA is replicated. M phase is when the 
duplicated chromosomes are divided into two daughter cells. G1 and G2 are gap phases 
between the S and M phases. 
Yeast cells have played crucial roles in unraveling molecular mechanisms of the 
cell cycle. The foundation for the molecular understanding of the cell cycle occurred in 
the early 1970’s, when Lee Hartwell and his colleagues screened for mutants of genes 
regulating the cell cycle in Saccharomyces cerevisiae, which they baptized cdc (cell-
division cycle) mutants (Pringle and Hartwell, 1981). Paul Nurse and his colleagues 
collected cdc mutants of Schizosaccharomyces pombe by a similar approach to 
Hartwell’s (Nurse, 2002). These collections of cdc mutants have been invaluable 
resources for the cloning and characterization of each CDC gene and the molecular 
understanding of the cell cycle. Another breakthrough was the discovery by Tim Hunt 
and his colleagues of a protein, cyclin, which was observed to oscillate during cell cycle 
progression. This temporal oscillation of cyclins is crucial for driving the cell cycle 
(Nasmyth, 1996; Wittenberg et al., 1990). 
 
This dissertation follows the style and format of Cell. 
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A key regulator in the yeast cell cycle is a cyclin-dependent kinase (CDK) 
encoded by CDC28 in Saccharomyces cerevisiae and cdc2 in Schizosaccharomyces 
pombe. Cyclins are primary regulators of the activity and probably the specificity of 
CDKs. Protein phosphorylation by the multiple cyclin-CDK complexes leads to events 
required at various cell cycle stages. 
 
Cell size and G1 regulation 
 
Cell size has been an important phenotype exploited in unraveling molecular 
mechanisms of the cell cycle. The reason was that the relative rate of progression 
through the cell cycle could be reflected through this easily measurable parameter. If the 
cell cycle progresses faster relative to cell growth, the cell will have a smaller size and 
vice versa. Therefore, measurement of size of cells with variant genotypes or 
environments would give important information on cell cycle progression in the 
corresponding condition. In fact, for a given condition, cell size remains unchanged after 
successive cell proliferations. Therefore, it was assumed that a mechanism existed 
whereby cell growth was coordinated with the cell cycle. Observations from earlier days 
showed that most eukaryotic cells spend a majority of time in G1 phase during the 
mitotic cell cycle and continue to grow until a commitment point for the initiation of 
DNA replication, which was named as “restriction point” for mammalian cells by Arthur 
Pardee (Pardee, 1974) and “Start” for Saccharomyces cerevisiae by Lee Hartwell 
(Hartwell and Unger, 1977). 
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A generally accepted model for cell size control states that the control of cell 
growth is performed at the point of the G1 to S transition. Understanding how cells 
decide to enter S phase has been one of the primary goals in the cell cycle field, 
especially because this research pertains to the better understanding of cancer cells, 
whose uncontrolled proliferation is thought to be due to their loss of tight regulation of 
the G1 to S transition. This essentially requires understanding of how complex signaling 
networks are processed from input signaling of extra-cellular growth factors and 
nutrients to give rise to the outcome of commitment to enter S phase. Because of this, 
biologists in the cell cycle field paid much attention to cell size control. In the 1970’s, 
small cell size (wee) mutants were identified in Schizosaccharomyces pombe and 
similarly whi mutants from Saccharomyces cerevisiae (Sudbery et al., 1980; Thuriaux et 
al., 1978). One of the wee mutants mapped to the cdc2 locus (Nurse and Thuriaux, 1980) 
and wee2 is a kinase inhibiting cdc2 function by phosphorylating cdc2 on tyrosine15 
(Parker et al., 1992). Several WHI genes turned out to be involved in the regulation of 
the G1 to S transition, which is consistent with the notion that the major cell size control 
point of Saccharomyces cerevisiae occurs at the G1 to S transition. For example, the 
WHI1-1 mutant is a gain-of-function mutant of a G1 cyclin, which was later re-named as 
CLN3 (Nash et al., 1988; Richardson et al., 1989). WHI3 is a negative regulator of 
Cln3p.  
 The other G1 cyclins of Saccharomyces cerevisiae, CLN1 and CLN2, were 
isolated as high copy suppressors of G1 arrest in a cdc28 mutant by Steven Reed and his 
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colleagues (Hadwiger et al., 1989). Cells removed all three G1 cyclins are non-viable but 
cells with any single G1 cyclin can proliferate (Richardson et al., 1989). 
 
Cyclins and cyclin-dependent kinases 
 
Saccharomyces cerevisiae has five CDKs, CDC28, PHO85, KIN28, SSN3, and CTK1, 
but only CDC28 is essential (Mendenhall and Hodge, 1998). The analogous gene in 
Schizosaccharomyces pombe is cdc2 (Doree and Hunt, 2002). CDKs are serine/threonine 
protein kinases. The CDK full consensus phosphorylation site is S/T-P-x-K/R and its 
minimum consensus site is S/T-P. Crystallographic study of Cdk2p by Sung-Ho Kim 
and his colleagues provides an important insight into a structural basis of CDK action 
(De Bondt et al., 1993). It has an active site cleft surrounded by two lobes formed by the 
N-terminus and the C-terminus. The N-terminal lobe contains the conserved PSTAIRE 
helix. The position of the T-loop, located in the C-terminus lobe, plays a crucial role in 
CDK activity. Without cyclin binding, the T-loop prevents access of a substrate to the 
active site cleft of CDK. Upon binding with cyclin it dislocates and the cleft is accessible 
to CDK’s substrates. CDK activity is regulated by four main mechanisms: cyclin 
binding, CDK inhibitors (CKIs) binding, activation by phosphorylation by CDK 
activating kinase (CAK), and inhibition by phosphorylation (Mendenhall and Hodge, 
1998). 
Cyclins are defined as proteins containing the cyclin box, which is a 100-amino 
acid residue region required for Cdk binding and activation. They are a family consisting 
of very diverse proteins, whose size ranges from 35 to 90 kD. The conserved cyclin box 
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forms the cyclin fold composed of a 5-helix bundle (De Bondt et al., 1993). Helices 3 
and 5 of the cyclin fold interact with the PSTAIRE helix of the active site cleft of CDKs. 
Such cyclin binding appears to influence significantly the conformation of the active site 
of CDKs. 
Cdc28p associates with 9 cyclins, of which three are G1 cyclins (Cln) and six are 
B-type cyclins (Clb). All the cyclins except for Cln3p temporally oscillate during the cell 
cycle (Nasmyth 1996). Two mechanisms are crucial for cyclin oscillation, transcriptional 
regulation and proteasome-mediated proteolysis. The abundance of Cln1p, 2p and 
Clb5p, 6p peaks in late G1, while that of Clb3p, 4p peaks at G2/M, and that of Clb1p, 2p 
peaks at M. G1 cyclins are very unstable because they contain a PEST region at their C-
termini, which is required for their proteasome-mediated proteolysis (Mendenhall and 
Hodge, 1998; Tyers et al., 1992). CLN3-1 and CLN3-2 alleles produce stable forms of 
Cln3p because they lack the PEST region. Clbs have a destruction box at the N-termini, 
which is required for their proteasome-mediated proteolysis (Mendenhall and Hodge, 
1998). 
Although it was long presumed that Cdc28p might directly phosphorylate many 
key components of cell cycle machinery, attempts to find the targets of Cdc28p were not 
very successful. Only a dozen proteins were identified as Cdc28p targets including H1 
histone (Langan et al., 1989), Far1p (Peter et al., 1993), Ste20p (Leeuw et al., 1998), and 
Sic1p (Verma et al., 1997). However, the recent development of many toolkits for yeast 
genetics and molecular biology facilitated the identification of Cdc28p substrates. The 
Cdc28as mutant protein, which can utilize a bulky ATP analogue, N6-(benzyl) ATP, 
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made it possible to follow the labeled proteins from 32P-N6-(benzyl) ATP because the 
other cellular kinases cannot use the analogue. This allowed proteins phosphorylated by 
Cdc28as protein to be discernible from proteins phosphorylated by other kinases. David 
Morgan and his colleagues performed genome-wide studies for putative Cdc28p 
substrates (Loog and Morgan, 2005; Ubersax et al., 2003). It was estimated that as many 
as 8% of yeast genes might encode putative substrates of the Clb2p/Cdc28p kinase 
complex. These results will provide a valuable resource for further detailed molecular 
studies. 
Cdc28p plays a crucial role in almost every point during the cell cycle. Different 
substrates seem to be phosphorylated by a different cyclin-Cdc28p kinase complex at 
various time points during the cell cycle. For example, Gin4p is phosphorylated in a 
Clb2p/Cdc28p-dependent manner, while Ste20p is phosphorylated by Cln2p/Cdc28p 
(Altman and Kellogg, 1997; Leeuw et al., 1998). However there seems to be substantial 
redundancy between cyclins because deletion of one cyclin gene often does not give rise 
to any discernible phenotypes. How Cdc28p’s substrate specificity is achieved has long 
been an issue of debate. Different spatial distributions and different temporal oscillations 
of individual cyclins may contribute to the Cdc28p’s substrate specificity (Edgington 
and Futcher, 2001; Miller and Cross, 2000). In fact, the abundance of Cdc28p does not 
oscillate and is relatively much higher than that of cyclins at a given time and space. As 
a consequence, presumably the identity and activity of cyclin will be a dominant 
determining factor for the activity and specificity of Cdc28p. Another possible 
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mechanism to accomplish substrate specificity of Cdc28p is by different spatial 
distribution and different temporal oscillation of its substrates. 
A mechanistic understanding of cell cycle regulation by cyclin/Cdc28p kinases 
provides an important insight into how CDKs execute cell cycle transitions in higher 
organisms because most key regulators of the cell cycle are evolutionary conserved. This 
premise was for example the basis of how Paul Nurse and his colleagues succeeded in 
cloning human Cdk1p by complementation using a Schizosacchomyces pombe cdc2 
mutant (Lee and Nurse, 1987). Steven Reed and his colleagues cloned human cyclins 
(cyclins C, D, and E) using Saccharomyces cerevisiae cyclin mutants (Lew et al., 1991). 
Similarly, Stephen Elledge and Matthew Spottswood cloned human Cdk2p using a 
Saccharomyces cerevisiae cdc28 mutant (Elledge and Spottswood, 1991).   
 
G1 to S transition (START) 
 
In early G1 phase the activity of Cdc28p remains low, as low Cdc28p kinase activity is 
necessary for anaphase to take place. However, the commitment to initiate DNA 
replication requires high activity of Cdc28p. Before this commitment point, cells grow 
and the process of ribosome biogenesis actively takes place. Accordingly, a cell’s 
protein synthesis capability increases and this leads to an increase of Cln3p/Cdc28p 
activity, which is an upstream regulator of G1 to S transition (Polymenis and Schmidt, 
1997; Jorgensen and Tyers, 2004). 
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A protein kinase, TOR (target of rapamycin), plays a key role in integrating 
nutrient-dependent signaling pathways to regulate translation and as a result cell size 
control (Raught et al., 2001). S6 kinase (S6K) and 4E-BP are two important effectors of 
TOR signaling. S6K phosphorylates ribosomal S6 protein and consequently positively 
regulates translation. 4E-BP is a negative regulator of the translation initiation factor, 
eIF4E, and is inhibited by TOR-mediated phosphorylation. The ultimate effect of this 
TOR action is thought to increase the abundance of Cln3p in late G1. Michael Polymenis 
and Emmett Schmidt found that abundance of Cln3p is regulated by translation in G1 
(Polymenis and Schmidt, 1997). 
Extensive molecular studies of the yeast cell cycle have revealed key features of 
the G1 to S transition regulation. A key event for the G1 to S transition is the activation 
of the G1 transcription program, which leads to a burst expression of more than 200 
genes including Cln1p, Cln2p, Clb5p and Clb6p (Spellman et al., 1998). These gene 
products play crucial roles in S phase processes such as DNA replication and bud 
formation. At the center of G1 transcription are two transcription factors, SBF (SCB 
(Swi4-Swi6-dependent cell cycle box) binding factor) and MBF (MCB (MluI cell cycle 
box) binding factor). SBF is a complex comprised of Swi4p and Swi6p, and MBF is a 
complex of Mbp1p and Swi6p. Swi4p and Mbp1p each bind specific DNA sequences. 
SBF and MBF remain bound to their promoters but in association with their inhibitor, 
Whi5p, until late G1 phase. The transcription of the target genes stays in a repressed 
state in this period. 
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Cln3p/Cdc28p and Bck2p positively regulate SBF and MBF by independent 
pathways (Wijnen and Futcher, 1999). Curt Wittenberg and his colleagues finally 
identified the long-pursued target of Cln3p/Cdc28p kinase in G1 transcription regulation 
(de Bruin et al., 2004). At late G1 when the activity of Cln3p/Cdc28p in the nucleus is 
thought to reach a critical threshold, Cln3p/Cdc28p phosphorylates Whi5p and 
dissociates it from SBF and MBF, leading to de-repression of the target genes (Costanzo 
et al., 2004; de Bruin et al., 2004). Whi5p then re-localizes from the nucleus into the 
cytoplasm. In mammals, the tumor suppressor protein Rb binds to and inhibits E2Fs, 
which are transcription activators for the genes required for the G1 to S transition. In 
many cancer cells, the function of Rb as a gate keeper of cell cycle entrance is lost (Chau 
and Wang, 2003). Whi5p appears to play an analogous role in Sacchromyces cerevisiae 
(Schaefer and Breeden, 2004). Whi5p and Rb have homology not in structure but in 
logic of function. How Bck2p activates SBF and MBF is currently unknown. 
Abundance and activity of Cln3p do not oscillate as the other cyclins do during 
cell cycle progression (Nasmyth, 1996). Cell growth appears to be required for Cln3p’s 
activation and the sub-cellular localization of Cln3p appears to be important in its 
positive regulation role for SBF and MBF (Edgington and Futcher, 2001; Wang et al., 
2004). Whi3p regulates Cln3p’s sub-cellular localization (Wang et al., 2004). 
At START, three prominent cell cycle events take place: DNA replication, bud 
formation and spindle pole body duplication. Cln1, 2p/Cdc28p trigger initiation of bud 
emergence (Gulli et al., 2000). Cln1, 2p/Cdc28p also phosphorylate Sic1p and Cdh1p 
and inactivate them through proteasome-mediated proteolysis (Nasmyth, 1996). 
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Degradation of Sic1p and Cdh1p, which are inhibitors of Clb-Cdc28p, leads to activation 
of Clb5, 6p/Cdc28p. This in turn initiates DNA replication and S phase starts. 
In addition to the transcriptional regulation mediated by SBF and MBF, there are 
multiple layers of regulation in G1 so that a cell does not enter S phase prematurely. 
CDK inhibitor proteins (CKIs) play a crucial role in S phase entrance. They prevent 
Cdc28p from being activated in G1 phase. The action of three CKIs, Sic1p, Far1p and 
Cdh1p, is well understood about how they antagonize Cdc28p activity. Far1p is 
expressed only in haploid cells and is a specific inhibitor of Cln/Cdc28p whereas Sic1p 
is a specific inhibitor of Clb/Cdc28p (Mendenhall and Hodge, 1998). Both Far1p and 
Sic1p are capable to exclude substrates from the Cdc28p active site. During late 
anaphase and G1, Cdh1p binds to the APC/C (anaphase-promoting complex/cyclosome), 
an E3 ubiquitin ligase. APC/C-Cdh1p complex recognizes Clbs for ubiquitination and 
then their proteolysis. The ultimate effect of these inhibitory pathways is to ensure that 
overall activity of Cdc28p remains low until late G1. G1 to S transition requires 
accumulated Cln/Cdc28p activity, which can override the multiple inhibitory actions and 
which can only be obtained in late G1. Cln/Cdc28p phosphorylates and inactivates Far1p 
through proteasome-mediated degradation (Henchoz et al., 1997). Similarly, Sic1p is 
phosphorylated by Cln/Cdc28p and marked for proteasome-mediated proteolysis (Nash 
et al., 2001). Intriguingly multiple phosphorylation of Sic1p provides molecular 
information of its switch-like degradation (Nash et al., 2001). Cdh1p is phosphorylated 
by Clb/Cdk1p and then dissociated from the APC/C complex, which then cannot 
recognize Clbs anymore for proteolysis (Zachariae et al., 1998). 
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Bud emergence and polarized growth 
 
For bud emergence to take place in the G1 to S transition, cells must re-organize the 
structure of the actin cytoskeleton. Saccharomyces cerevisiae has at least four distinct 
structures of actin cytoskeleton: actin cables, cortical patches, a cytokinetic ring, and the 
cap (Adams and Pringle, 1984). In late G1, cortical patches assemble to an area where 
the bud tip is to form, and actin cables orient from the patches. The assembled actin 
structures guide the delivery of secretory vesicles, which are required for bud emergence 
and growth (Pruyne et al., 2004). 
In late G1, Bud1p/Rsr1p GTPases seem to play a key role in the determination of 
incipient bud site (Casamayor and Snyder, 2002). Around Bud1p/Rsr1p, a large protein 
complex, composed of Bem1p, Cdc24p, Cdc42p, Cla4p, and Ste20p, is formed (Bose et 
al., 2001). Cln1, 2p/Cdc28p are thought to play an important role in this process by 
regulating Cdc24p phosphorylation (Gulli et al., 2000). BEM1 was identified as a gene 
required for bud emergence. It is a scaffold protein containing two SH3 domains, a PX 
domain and a PB domain from N- to C-termini (Irazoqui et al., 2003). The second SH3 
domain interacts with Cla4p, Ste20p, Boi1p and Boi2p. The PX domain interacts with 
phosphoinositides and the PB domain interacts with Cdc24p. Bem1p also interacts with 
Cdc42p through its N-terminal region. Formation of a complex including Bem1p, 
Cdc42p, Cla4p, and Ste20p appears to be important to the establishment of a polarized 
actin cytoskeleton. Actin cables formed toward the bud tip provide a road for the 
secretory vesicles to migrate to the bud, supplying materials required for the growth of 
bud. 
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Organelle inheritance 
 
In a eukaryotic cell, organelles are not de novo synthesized but instead are inherited from 
the mother cell (Warren and Wickner, 1996; Weisman, 2003). Inheritance processes of 
some organelles such as the Golgi apparatus are quite contrasting between 
Saccharomyces cerevisiae and mammalian cells (Warren and Wickner, 1996). 
Inheritance of human Golgi apparatus takes place in M phase through Golgi 
fragmentation into many smaller vesicles, which partition into two daughter cells. The 
vesicles from mitotic Golgi fragmentation then fuse in G1 phase to form a new copy of 
Golgi. In Saccharomyces cerevisiae, organelle inheritance usually starts in S phase when 
the bud grows. A part of the mother cell’s organelles moves along actin cables into the 
bud, where they form new organelles by homotypic fusion. 
Homotypic fusion is defined as membrane fusion between the same 
compartments. During the whole process of organelle inheritance, the organelle is first 
fragmented in the mother cell to smaller vesicles, which are then translocated to the 
daughter cell and finally fused to form a new copy of the organelle. All of these 
processes will be closely related with homotypic fusion. To coordinate organelle 
inheritance with the cell cycle, homotypic fusion may somehow be linked to the cell 
cycle machinery.  In fact, a human Golgi’s tethering factor, GM130, was shown to be 
phosphorylated in vitro by cyclinB/Cdk1p and its phosphorylation disrupts trans-
interaction with another tethering factor, p115, on other membrane (Lowe et al., 1998). 
This phosphorylation was proposed to be crucial for mitotic Golgi fragmentation. 
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At present we do not have an established molecular picture of organelle 
inheritance. Studies on yeast vacuole inheritance have provided some important insights 
into molecular mechanisms of organelle inheritance. 
 
Vacuole/lysosome 
 
The yeast vacuole is an organelle equivalent to the mammalian lysosome and the most 
extensively studied organelle in Saccharomyces cerevisiae. The main function of the 
vacuole is to maintain cellular homeostasis. Vacuole serves as a reservoir of small 
molecules such as amino acids, small ions, and polyphosphates, and so it has a lower 
density than other organelles (Wiemken and Durr, 1974). It also contains a large 
amounts of various hydrolases, including carboxypeptidase Y (CPY), alkaline 
phosphatase (ALP), proteinase A (PrA), proteinase B (PrB), and aminopeptidase I (API) 
(Bryant and Stevens, 1998). The vacuole is the main site for degradation of proteins, 
lipids and even of whole organelles, and is also involved in the regulation of receptor-
mediated signaling pathways. 
The vacuole is a large organelle, occupying about 25% of total cell volume 
(Wiemken and Durr, 1974), and has a low copy number, 1-5 vacuoles per cell (Wickner, 
2002). There are several vacuole-specific dyes which are commercially available. In 
particular, CDCFDA and FM4-64 are very useful (Vida and Emr, 1995). They facilitate 
molecular and cellular studies on the vacuole. CDCFDA diffuses into the cytoplasm and 
is hydrolyzed by vacuolar hydrolases in the vacuolar lumen (Breeuwer et al., 1995). The 
cleaved product becomes fluorescent in the acidic vacuole lumen. It becomes charged 
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after cleavage and is thus retained in the vacuole. FM4-64 is a lipophilic fluorescent 
compound which can stain the vacuolar membranes. It is internalized from the plasma 
membrane by endocytosis and then targeted into the vacuolar membrane. 
Wild-type vacuoles have a round-shaped morphology. Genes required for the 
normal morphology were identified and termed as VAM (vacuole morphology). Vacuole 
morphology is categorized into five classes (Class A, B, C, D, and E) (Catlett and 
Weisman, 2000). Class A is wild-type vacuole morphology. Class B is vacuole 
morphology of multiple small vacuoles. Class C is highly fragmented vacuoles. Class D 
is a single, enlarged vacuole morphology. Class E vacuoles have a large vacuole 
compartment surrounded by many membrane vesicles. Vacuolar pH is about 6.2 in wild-
type cells. VPH (vacuole pH) genes were identified, which are required for acidic 
vacuolar pH (Preston et al., 1989). 
There are five targeting pathways to the vacuole (Bryant and Stevens, 1998; Burd 
et al., 1998). Two pathways, the ALP pathway and the CPY pathway, share the ER to 
late Golgi pathway along the secretory pathway. The ALP pathway takes a route from 
the late Golgi to the vacuoles. The CPY pathway takes a route from the late Golgi 
through the prevacuolar endosome to the vacuoles. The other vacuole targeting pathways 
are the cytoplasm-to-vacuole pathway, the autophagy pathway, and the endocytosis 
pathway. API takes the cytoplasm-to-vacuole pathway, in which a soluble protein in the 
cytoplasm is surrounded by a membrane to form a vesicle, which is finally fused with 
vacuolar membrane. The autophagy pathway recently received much attention because 
dysfunction of human homologs of some genes involved in the pathway is known to be 
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linked to some diseases (Shintani and Klionsky, 2004). Autophagy involves the 
formation of an autophagosome, a double-layered membrane-bound structure engulfing 
cytoplasmic composites. The autophagosome fuses with vacuolar membrane and a single 
membrane-bound structure enters into the vacuole lumen, where it is degraded by 
vacuolar hydrolases. In the endocytosis pathway, small vesicles formed by invagination 
of plasma membrane, which are first delivered to early endosomes, then to 
multivesicular late endosomes, and finally to vacuoles. The vesicles in the 
lysosome/vacuole are degraded by vacuolar hydrolases. This, also called multi-vesicular 
body (MVB) pathway, is one pathway that extra-cellular stimuli use to reach the 
cytoplasm to execute cellular effects. This pathway is thought to down-regulate the 
growth factor/pheromone signaling. This pathway is especially important for signal 
transduction pathways involved in the control of cell growth and development 
(Katzmann et al., 2002). The genes involved in each pathway are well characterized. 46 
complementation groups of VPS (vacuolar protein sorting) genes have been identified 
(Jones et al., 1997). Some of these genes are involved in the Golgi-to-endosome, the 
endosome-to-vacuole, or the retrograde endosome-to-Golgi pathway (Jones et al., 1997). 
 
Membrane fusion 
 
Membrane fusion is a reaction of fundamental importance in eukaryotic cells, essential 
for membrane trafficking, protein targeting and organelle inheritance. James Rothman 
and his colleagues identified key players of the membrane fusion machinery in the 
1980’s. Using in vitro membrane fusion assays, they identified NSF (N-ethyl maleimide-
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sensitive factor), SNAP (soluble NSF attachment protein) and SNARE (SNAP receptor), 
all of which play crucial roles in membrane fusion (Rothman, 1994). Randy Schekman 
and his colleagues identified 23 genes required for protein targeting along the yeast 
secretory pathways (sec genes), some of which are involved in membrane fusion 
(Bonifacino and Glick, 2004; Novick et al., 1981; Novick et al., 1980). 
NSF is an ATPase, a founding member of the AAA protein family (ATPases 
associated with diverse cellular activities) and forms a hexameric ring (Bonifacino and 
Glick, 2004). SNAP is required for NSF to bind to the membrane. SNAREs are 
membrane-associated receptors of SNAP. Rothman and his colleagues proposed the 
SNARE hypothesis that the specificity of membrane fusion between two compartments 
is determined by trans-SNARE interaction (Sollner et al., 1993). It asserts that the 
interaction between a SNARE on the vesicle membrane (v-SNARE) and a SNARE on 
the target membrane (t-SNARE) is a determining factor for the specificity of two 
membranes. The trans-SNARE complex has a four-helix bundle structure comprised of 
three t-SNAREs and one v-SNARE (Sutton et al., 1998). The SNARE hypothesis 
triggered extensive studies on molecular mechanisms of membrane fusion and its 
specificity (Chen and Scheller, 2001; Guo et al., 2000; Pfeffer, 1996; Rothman, 2002). 
The trans-SNARE complex was shown to be the minimal machinery (SNAREpin) 
required for membrane fusion (Weber et al., 1998) and a determining factor for 
compartmental specificity of membrane fusion at least in artificial liposomes (McNew et 
al., 2000). Furthermore, each membrane compartment appears to have unique SNAREs 
(Hay and Scheller, 1997; Pelham, 1999). All these support the SNARE hypothesis. 
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However, the SNARE complex is probably not the only factor that determines 
compartmental specificity in vivo because specific inhibition of the SNAREs does not 
block vesicle docking (Guo et al., 2000; Pfeffer, 1999). In addition, t-SNAREs are 
distributed uniformly over the plasma membrane rather than on a limited area of vesicle 
fusion in Drosophila and the squid giant synapse. 
Membrane fusion is a multi-step process which can be defined as a sequence of 
distinct steps, such as priming, tethering, docking and fusion (Pfeffer, 1999). In priming, 
NSF disassembles cis-SNARE complex on the same membrane. Tethering was proposed 
as a loose interaction state in which the associations extend over distances of more than 
about half the diameter of a vesicle from a given membrane surface (>25 nm). 
Remarkably, a tethering factor Uso1p has a coiled-coil structure of 150 nm long, which 
is suited for a tethering function. Docking was proposed as a tighter and more stable 
state, in which two membranes are within a bilayer’s distance (<5-10 nm), and the trans-
SNARE complex is established between two membrane compartments. Fusion is a stage 
where two membrane bilayers become one continuing membrane bilayer. All these 
processes are driven by protein-protein interactions. Membranes of each compartment 
have different tethering and docking factors (Guo et al., 2000; Pfeffer, 1999). Tethering 
and docking factors probably play an important role in determining compartment 
specificity. 
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Vacuolar inheritance and vacuolar homotypic fusion 
 
Vacuoles, like other organelles, are not de novo synthesized in a daughter cell but 
inherited from the mother cell (Warren and Wickner, 1996; Weisman, 2003). Vacuolar 
inheritance is thought to be coordinated with cell cycle progression. In S phase, a tubular 
vesicle structure is formed from the mother cell’s vacuoles and moves along an actin 
cable toward the bud, where they fuse to form a new copy of vacuoles by vacuolar 
homotypic fusion. Genes involved in vacuolar inheritance (VAC) have been identified. 
Key players in vacuolar inheritance are Myo2p, Vac8p and Vac17p (Tang et al., 2003). 
Vac17p is a component of the vacuole-specific Myo2p receptor. Vac8p is a vacuolar 
membrane protein, which interacts with Vac17p. Myo2p is a motor protein, capable of 
moving along actin cables. Myo2p/Vac17p/Vac8p complex connects a vacuole vesicle to 
the actin cable. The motoring action of Myo2p produces the driving force for the vesicle 
movement. Transported vesicles are deposited in the bud by dissociating the 
Myo2p/Vac17p/Vac8p complex through degradation of the PEST domain of Vac17p 
(Tang et al., 2003). 
A current molecular picture of vacuolar homotypic fusion is shaped by the 
extensive studies performed by Bill Wickner and his colleagues (Wickner and Haas, 
2000). They established an in vitro fusion assay, which is an important tool for the 
biochemical study of the fusion reaction. Like other analogous in vitro membrane fusion 
assays, this assay exploits biochemical complementation. Vacuole liposomes are 
prepared from two strains of pho8Δ cells and pep4Δ/prb1Δ cells. They are mixed with 
cytosol, ATP, and salts and incubated to allow for vacuole fusion to take place. PHO8 
  
19  
 
 
 
encodes alkaline phosphatase (ALP). PEP4 and PRB1 encode vacuolar hydrolases, 
which are required for the processing of pro-ALP to mature active ALP. Only when two 
vacuole membranes fuse and their components are mixed, can fully matured active ALP 
form. ALP activity can be measured by spectrophotometry. Alternatively, vacuole fusion 
can be directly evaluated by microscopy after vacuole staining. 
Using this biochemical assay, combined with genetics, Bill Wickner and his 
colleagues identified many players involved in the fusion reaction. Vam3p and Vam7p 
are vacuolar t-SNAREs (Wickner, 2002). Nyv1p, Vti1p and Ykt6p are vacuolar v-
SNAREs. HOPS (homotypic fusion protein sorting) complex is composed of tethering 
factors of vacuolar homotypic fusion. It is composed of Vps 11, 16, 18, 33, 39, 41p. 
Sec17p is yeast SNAP and Sec18p is yeast NSF, both of which are involved in vacuolar 
homotypic fusion (Haas and Wickner, 1996). Several small GTPases such as Ypt7p, 
Cdc42p, and Rho1p are known to play a key role in the vacuole membrane fusion. 
Phosphoinositides also play a crucial role in vacuolar membrane trafficking and 
fusion (Burd et al., 1998). Saccharomyces cerevisiae has phosphoinositol (PI), 
phosphoinositol 3-phosphate (PI(3)P), phosphoinositol 4- phosphate (PI(4)P), and 
phosphoinositol 3, 5-diphosphate (PI(3,5)P2). Membranes of different organelles have 
characteristic distribution of PI or PIPs of their own. The Golgi membrane has PI(3)P 
and PI(4)P while the endosome has PI(3)P and PI(3,5)P2. Vps34p is a PI 3-kinase 
converting PI to PI(3)P on the Golgi and endosome membranes. Pik1p is a PI 4-kinase 
catalyzing PI to PI(4)P on Golgi membrane. Fab1p is a PI(3)P 5-kinase catalyzing the 
conversion of PI(3)P to PI(3,5)P2  on the endosome and vacuole membranes. PI or PIPs 
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interact with specific protein domains. PI(3)P interacts with the FYVE (Fab1p, Ygl023p, 
Vac1p, Eea1p) domain. PH (Pleckstrin homology) domain interacts with various PI or 
PIPs (Maffucci and Falasca, 2001). The different distributions of PI or PIPs endow 
identity to individual organelles by recruiting different proteins. The importance of 
phosphoinositides in vacuolar physiology is well exemplified by fab1Δ mutant cells, 
which have a very enlarged single vacuole filling almost the entire cell volume (Efe et 
al., 2005). The cells are very sick, probably because of vacuolar dysfunction. In fact, 
phosphoinositides play an important role in the regulation of human cell proliferation 
(Mayo and Donner, 2002). 
Bill Wickner and his colleagues proposed that vacuolar homotypic fusion is 
composed of four sequential steps named priming, tethering, docking and fusion (Mayer 
et al., 1996). They characterized a temporal sequence of the vacuolar homotypic fusion 
reaction using several inhibitors and antibodies, which were known to block a specific 
step. In the priming step, the cis-SNARE complex is first disassembled, which is 
dependent on Sec18p (yeast NSF) and Sec17p (yeast SNAP). Then, the tethering factor 
HOPS complexes on the opposing membranes interact, this interaction being dependent 
on Ypt7p. The trans-SNARE complex then forms and finally Ca++ triggers the 
membrane fusion.  
Overall, vacuolar homotypic fusion appears to be a very complex reaction, which 
is a multi-step reaction involving many proteins. Several lines of evidence favor this 
notion. First, a genome-wide study showed that more than 100 genes are involved in the 
vacuolar homotypic fusion reaction (Seeley et al., 2002). Second, cis-SNAREs exist in a 
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large 65S complex before the priming step. It seems that large complex 
assembly/disassembly takes place during the entire fusion reaction from the priming step 
to final membrane fusion. Third, at least three GTPases are known to be involved in the 
vacuolar homotypic fusion. This adds an additional layer to an already complex 
regulatory network because the activity of each GTPase is regulated by a specific 
GTPase activing protein (GAP), GTP exchange factor (GEF) and GTPase dissociation 
inhibitor (GDI) in each case. A GTPase, Ypt7p, is required for the tethering step. Rho1p 
and Cdc42p act after Ypt7p to regulate vacuole docking (Eitzen et al., 2001; Muller et 
al., 2001).  
Cdc42p appears to be involved in vacuolar homotypic fusion through the 
regulation of actin polymerization. The reports on how actin regulates membrane fusion 
are quite contradictory (Eitzen, 2003). Actin was generally thought to be a negative 
regulator of membrane fusion because it seemed to act as a barrier to formation of trans-
SNARE complex. However, after the docking stage, in which trans-SNARE complex 
forms, it might facilitate membrane fusion. Therefore, the role of actin in membrane 
fusion seems quite complicated, and it can facilitate or inhibit membrane fusion 
depending on at which step it acts.  
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Membrane traffic, cell size control and CLN3 
 
A feature of eukaryotic cells is that they have many intracellular membrane-bound 
organelles. These intracellular membrane-bound structures were observed as early as the 
late nineteenth century by Camillo Golgi and Elie Metchnikoff (Mellman and Warren, 
2000). In the middle of the twentieth century, George Palade and his colleagues showed 
the existence of biochemically and physically distinct organelles using cell fractionation 
and enzymatic assays combined with electron microscopy (Palade, 1975). They 
elucidated the basic principles of the secretory pathway using EM autoradiography. 
Proteins were pulse-labeled and after various chase periods, the cell was observed by 
EM to follow the labeled proteins’ pathway. They found that secretory proteins are 
synthesized in the endoplasmic reticulum (ER), translocated into the Golgi complex and 
secreted across the plasma membrane by exocytosis. Proteins are translocated between 
distinct organelle compartments via transport vesicles, which bud from one organelle 
and fuse into another. 
Another important pathway in membrane traffic is endocytosis. This is the 
pathway for extracellular materials to enter the cell. After binding to a cognate receptor 
on the plasma membrane, the extracellular material is internalized into the cell as a 
vesicle and targeted to late endosomes. 
There are numerous, dynamic fluxes of vesicles between the plasma membrane 
and organelles as well as between organelles.  For Sacchromyces cerevisiae to grow, 
continuous expansion of the cell wall and plasma membrane is required. Materials 
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should be continuously carried by secretory vesicles and supplied to the area of the cell 
wall and plasma membrane from intracellular compartments by exocytosis. Membrane 
trafficking may be closely involved in the regulation of cell size and morphogenesis. 
Cell size and morphogenesis will be altered as a result of a net change of the vesicle 
fluxes between compartments. However, most, if not all, mechanistic explanations of 
cell size control were provided in terms of molecule-to-molecule interactions, and 
without taking into account the compartmentalization of eukaryotic cells. 
CLN3 is a well-known cell size regulator. Mutations in CLN3 give rise to 
significant cell size changes. Hypermorphic alleles, CLN3-1 and CLN3-2, make a cell 
small, whereas CLN3 deletion leads to an enlarged cell. A generally accepted molecular 
explanation is that Cln3p/Cdc28p regulates the G1 transcription program and as a 
consequence temporally controls the G1 to S transition. According to this model, gain-
of-function mutations in CLN3 will activate the transcriptional program at an earlier 
point. Cells can enter S phase at a smaller cell size, and as a consequence, the overall 
cell size of this mutant will be diminished. As for loss-of-function CLN3 mutants, the 
opposite effect will occur for the opposite reason. This model seems to be well suited for 
explaining the cell size phenotypes of CLN3 mutants because the role of CLN3 to 
activate the G1 transcription program is well established. Furthermore, this model is 
consistent with the recent observation of the genome-wide study by Mike Tyers and his 
colleagues that cell size deregulation was observed among gene deletion mutants of the 
ribosome biosynthesis pathways, which impact on the regulation of G1 to S transition 
(Jorgensen et al., 2002). 
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However it should be mentioned that they also observed that most of the cell size 
mutant genes do not control G1 to S transition. Therefore, although the G1 to S 
transition is an important point for the coordination of the cell cycle with cell growth, the 
possibility should not be overlooked that overall cell size may be determined by diverse 
ways at various points during cell cycle progression. In fact, cells continue to grow after 
the G1 to S transition. Though ribosome biogenesis and translation efficiency were 
proposed as the main theme for cell size control, the broad diversity of the genes 
involved in cell size control may reflect that cell size is determined at multiple levels 
during cell division and cell growth. 
Another scenario is that the size of individual organelles is autonomously 
controlled by the genetic program and the environment, and that the size of individual 
organelles disproportionately contributes to overall cell size in different genetic and 
environmental conditions. However, this possibility was almost out of consideration 
until recently, when we showed that there is a disproportional change in vacuole size 
compared to overall cell size change in cln3Δ cells of Saccharomyces cerevisiae (Han et 
al., 2003). To our surprise Cln3p/Cdc28p directly regulates vacuolar homotypic fusion 
and vacuolar copy number by a post-translational mechanism. This reveals a novel role 
of Cln3p independent of its well-established function in the activation of G1 
transcription. It is the first demonstration in yeast that a cell cycle regulator directly 
regulates an organelle’s membrane fusion. I will describe these exciting findings in 
CHAPTER III. 
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Remarkably we succeeded in identifying the target of Cln3p/Cdc28p in vacuole 
fusion. A scaffold protein, Bem1p, is required for the vacuolar function of Cln3p. 
Furthermore we succeeded in pinpointing the target site (Ser72) of Cln3p/Cdc28p on 
Bem1p, whose phosphorylation gives rise to a crucial biological consequence in vacuole 
fusion. In CHAPTER IV, I will describe these surprising and exciting findings. 
 
  
26  
 
 
 
CHAPTER II 
MATERIALS AND METHODS 
 
Strains and DNAs 
 
Cell cultivation, media and yeast molecular biology techniques were performed as 
described by Kaiser et al (Kaiser et al., 1994), unless otherwise indicated. Most of the 
strains and plasmids used in this study are listed in Tables 2.1 and 2.2, respectively. The 
YEp-VAC8 and YEp-CLN2 plasmids were gifts from L. Weismanm (Wang et al., 2001) 
and B. Andrews (Ogas et al., 1991), respectively. The plasmid used to disrupt CLN3 in 
vac8Δ cells (BY4741 background) has been described previously (Polymenis and 
Schmidt, 1997). 
 The CLN3-2 strains were generated by transformation of the corresponding wild-
type strains with a URA3+ low-copy-number centromeric plasmid carrying the CLN3-2 
allele (Cross, 1990). In the cln2Δ strain (BY4741 background), we disrupted CLN1 
(cln1Δ::URA3) by  PCR-based single-step gene replacement (Kaiser et al., 1994). The 
PCR-product was generated by amplification of URA3 sequences with the following 
oligonucleotide primers: 5’-
CCACCACTCCACTGCTCGTTAGCTATTTCTGTAAAATAAATAAAAAGATCAT
GTCGAAAGCTACATATAAGGAACG –3’, and 5’-
TAGTATTCCGTTATTAATTAAGTATATATGTAGGCTTGATGAGAAAATGGTC
AGTTTTGCTGGCCGCATCTTCTC-3’. 
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Table 2.1 Saccharomyces cerevisiae strains and their relevant genotypes 
Strain Relevant genotype Source 
BY4741 MATa his3Δ leu2Δ met15Δ ura3Δ Res. Genetics 
BY4742 MATα his3Δ leu2Δ met15Δ ura3Δ Res. Genetics 
BY4743 BY4741/BY4742 Res. Genetics 
W303a MATa ade2 trp1 leu2 his3 ura3 can1 B. Futcher 
A364A MATa ade1 ade2 ura1 his7 lys2 tyr1 gal1 SUC mal ATCC 
185-3-4g cdc28::cdc28-1 (A364A otherwise) ATCC 
GT106 cln3Δ::URA3 (W303a otherwise) B. Futcher 
GT108 CLN3-3HA::URA3 (W303a otherwise)  B. Futcher 
MT240 CLN2-3HA::URA3 (W303a otherwise) B. Futcher 
7503198 CLN2-TAP::his3MX (BY4741 otherwise) Open Biosystems 
7499374 BEM1-TAP::his3MX (BY4741 otherwise) Open Biosystems 
33340 bem1Δ::kanMX/bem1Δ::kanMX (BY4743 otherwise) Res. Genetics 
DKY6281 MATa lys2 trp1 ura3 his3 leu2 suc2 pho8Δ::TRP1 W. Wickner 
BJ3505 MATa lys2 trp1 ura3 his3 gal2 can prb1 pep4Δ::HIS3 W. Wickner 
13340 bem1Δ::kanMX (BY4742 otherwise) Res. Genetics 
SCMSP47 cln1Δ::KanMX cln2Δ::URA3 (BY4741 otherwise) (Han et al., 2003) 
SMY01 bem1Δ::KanMX cln3Δ::URA3 (BY4741 otherwise) This study 
30366 cln3Δ::kanMX/cln3Δ::kanMX (BY4743 otherwise) Res. Genetics 
366 cln3Δ::kanMX (BY4741 otherwise) Res. Genetics 
1036 cln2Δ::kanMX (BY4741 otherwise) Res. Genetics 
4105 pep3Δ::kanMX (BY4741 otherwise) Res. Genetics 
253 vac8Δ::kanMX (BY4741 otherwise) Res. Genetics 
4738 clb1Δ::kanMX (BY4741 otherwise) Res. Genetics 
5534 clb2Δ::kanMX (BY4741 otherwise) Res. Genetics 
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Table 2.1 continued. 
Strain Relevant genotype Source 
3853 clb3Δ::kanMX (BY4741 otherwise) Res. Genetics 
4159 clb4Δ::kanMX (BY4741 otherwise) Res. Genetics 
5535 clb5Δ::kanMX (BY4741 otherwise) Res. Genetics 
4739 clb6Δ::kanMX (BY4741 otherwise) Res. Genetics 
DOM90 bar1::HisG (W303a otherwise) D. Morgan 
DOM30 cdc28::cdc28-as1 (DOM90 otherwise) D. Morgan 
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Table 2.2 Plasmids and their relevant characteristics 
Plasmid Relevant characteristic Source 
p205 CEN [CLN3-2D] URA3 F. Cross 
PDLB2226 CEN [BEM1-12MYC] LEU2 D. Lew 
PDLB2226-S72A CEN [BEM1-S72A-12MYC] LEU2 This study 
PDLB2226-S72D CEN [BEM1-S72D-12MYC] LEU2 This study 
PTH113 2µ [CDC24] LEU2 T. Höfken 
PTH114 2µ [CDC42] LEU2 T. Höfken 
PDLB2374 2µ [BEM1-12MYC] LEU2 D. Lew 
PDLB2375 2µ [BEM1-P208L-12MYC] LEU2 D. Lew 
PDLB2377 2µ [BEM1-P355A-12MYC] LEU2 D. Lew 
PDLB2378 2µ [BEM1-R369A-12MYC] LEU2 D. Lew 
PDLB2379 2µ [BEM1-K482A-12MYC] LEU2 D. Lew 
pBAD-DCR2 [PBAD-DCR2-TAG]  This study 
pBAD-CLN3 [PBAD-CLN3-TAG]  This study 
pBAD-BEM1 [PBAD-BEM1-TAG]  This study 
pBAD-BEM1-S72A [PBAD-BEM1-S72A-TAG]  This study 
pBAD-BEM1-S72D [PBAD-BEM1-S72D-TAG]  This study 
pBAD-CDC42 [PBAD-CDC42-TAG]  This study 
BG1805-DCR2 2µ [PGAL1-DCR2-TAG] URA3 Open Biosystems 
BG1805-CLN3 2µ [PGAL1-CLN3-TAG] URA3 Open Biosystems 
BG1805-BEM1 2µ [PGAL1-BEM1-TAG] URA3 Open Biosystems 
BG1805-BEM1-S72A 2µ [PGAL1-BEM1-S72A-TAG] URA3 Open Biosystems 
BG1805-BEM1-S72D 2µ [PGAL1-BEM1-S72D-TAG] URA3 Open Biosystems 
BG1805-CDC42 2µ [PGAL1-CDC42-TAG] URA3 Open Biosystems 
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To generate the bem1Δ cln3Δ strain (SMY01) we disrupted one CLN3 copy in 
diploid bem1Δ cells as described previously (Polymenis and Schmidt, 1997). The 
resulting heterozygote was sporulated, and the segregants were obtained by random 
spore analysis (Kaiser et al., 1994). All the single cyclin deletions and the bem1Δ strain 
in the BY4741 background were obtained by sporulation of the corresponding 
homozygous diploid deletion strains distributed from Research Genetics. The 
phenotypes reported for each strain were obtained after examining several independent 
transformants or segregants for the strain in question. 
 The putative phosphorylation site amino acid substitutions were introduced in the 
BEM1-12MYC low copy centromeric plasmid pDLB2226 (Irazoqui et al., 2003). We 
first PCR-amplified BEM1 sequences from pDLB2226 using forward primers that 
encoded the desired mutation (BEM1-S72A-FWD: 5’- 
CCAAAAAACAGACATAATTCTAAAGATATTACTGCTCCAGAGAAAGTTATA
AAAGCCAAATAC-3’; BEM1-S72D-FWD: 5’-
CCAAAAAACAGACATAATTCTAAAGATATTACTGATCCAGAGAAAGTTATA
AAAGCCAAATAC-3’), and a reverse primer corresponding to sequences up to position 
+574 of the BEM1 ORF (BEM1-(+574)-REV: 5’-
CGACCAATTGGCTTAGCAATGAACC-3’). The PCR products were purified by 
agarose gel electrophoresis and used as primers in a second PCR reaction with 
pDLB2226 as template and a forward primer corresponding to BEM1 sequences up to 
position –186 (BEM1-(-186)-FWD: 5’-ATTACCCTAAACGGACAAATG-3’). The 
PCR product of this reaction was also purified by agarose gel electrophoresis and co-
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transformed into yeast cells together with plasmid pDLB2226, which was previously 
linearized with SmaI and HindIII digestion (cutting at positions -166 to +330 of the 
BEM1 ORF, respectively). The gap-repaired plasmid derivatives were then recovered 
from yeast transformants by standard methods (Kaiser et al., 1994).  
 To construct plasmids for bacterial expression, we digested the BG1805-based 
plasmids (purchased from Open Biosystems, CA; see Table 2.2) with AgeI, which cuts 
once in the GAL1 promoter all the BG1805 plasmids used here. The digested plasmids 
were then transformed into a Ura- yeast strain for gap-repair together with an 
oligonucleotide that encodes the arabinose PBAD promoter and ribosome binding site 
(Guzman et al., 1995) (GAL1-PBAD-FWD: 5'-
CGGGAACGGATTAGAAGCCGCCGAGCGGGTGACGCTTTTTATCGCAACTCTC
TACTGTTTCTCCATACCCGTTTTTTTGGATGGAGTGAATATACCTCTATACTT
TAACGTCAAGGAGAA-3'). GAL1-PBAD-FWD at its 5’ end carries sequences 
complementary to GAL1 sequences upstream of the AgeI site, and at its 3’ end 
sequences complementary immediately upstream of the ATG start codon of the ORF in 
the BG1805 plasmids, which correspond to the bacteriophage λ attR1 site. 
The mutant plasmid derivatives were sequenced to verify the introduced 
mutation and the absence of any other mutations at the Genome Technologies 
Laboratory of Texas A&M University. 
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Microscopy and flow cytometry 
 
For microscopic examination of vacuolar membranes the cells were stained with FM4-
64, N-(3-triethylammoniumpropyl)-4-(6-(4-diethylamino)phenyl)hexatrienyl)pyridinium 
dibromide, as described by Wang et al (Wang et al., 1996). Briefly, 3x106 cells were 
collected from exponentially growing cells at a cell density of 5x106/ml in YPD and re-
suspended in 0.25ml of YPD. 1 µl of 20mM FM4-64 (Molecular Probes, Eugene, OR) 
was added. It was incubated at 30oC in a shaking incubator for about 1-2 cell population 
doublings. Cells were collected, sonicated and washed with YPD. After re-suspending in 
about 10 µl of YPD, cells were mounted on a glass slide to observe under the 
microscope. For the experiments shown in the figure on p.50 with the temperature-
sensitive cdc28-1 strain, the cells were shifted to their non-permissive temperature (37 
°C) for 3h, stained with FM4-64 for 1 h at 37 °C, cultured in dye-free medium at 37 °C 
for 2 h, and then examined microscopically. 
Cells and purified vacuoles were stained with the vital vacuolar stain CDCFDA, 
as described previously (Roberts et al., 1991). CDCFDA was added at 10 µM in the 
culture media (with 50 mM sodium citrate, pH 5.0) for 20 minutes. The cells were then 
examined either by fluorescence microscopy or flow cytometry. 
For samples analyzed by confocal microscopy, total cellular volume was 
evaluated by staining the exterior of the cells with Rhodamine Red, according to the 
manufacturer’s instructions (Molecular Probes, OR), while vacuoles were visualized 
using CDCFDA as we described above. Data for each strain were obtained from at least 
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3 different microscope fields, and we examined a minimum of 20 planes for each 
microscope field. The fluorescent area per cell was measured using Adobe Photoshop® 
software. The sum of the areas corresponding to each cell was then used as an estimate 
of volume. 
Electron microscopic analysis of ultrathin sections and acid phosphatase 
localization using cerium chloride as a capture agent to visualize the vacuole was carried 
out at the Texas A&M Microscopy and Imaging Center. Cells were fixed in a 2% 
acrolein, 0.1M sodium cacodylate solution (pH 7.4) on ice for 30 min. The cells were 
then washed four times, 15 min each time, in 5% sucrose, 1% DMSO, 0.1M sodium 
cacodylate solution (pH 7.4). The reaction mixture for acid phosphatase localization was 
0.1M sodium acetate (pH 5.0), 5% sucrose, 1mM β-glycerophosphate, 2mM cerium 
chloride, and 0.01% Triton X-100. The cells were first incubated for 30 min at 30ºC in 
reaction mixture lacking the substrate (β-glycerophosphate), followed by a 1h incubation 
in complete reaction medium at 30ºC. The reaction was stopped by two washes in ice-
cold solution of 0.1M sodium acetate (pH 5.0), 5% sucrose, followed by two washes in 
ice-cold 0.1M sodium cacodylate solution (pH 7.4). The cells were then incubated 
overnight at 4ºC in a solution containing 1% OsO4, 5% sucrose and 0.1M sodium 
cacodylate (pH 7.4). The samples were then dehydrated in graded ethanol series, 
embedded in epoxy resin, sectioned and examined without post-staining. 
For flow cytometry for cellular DNA content (the figure on p.61), cells (1x107 
cells/ml) were fixed overnight in an Ethanol-PBS solution (mixed at a 7:3 ratio). They 
were then re-suspended in 50 mM sodium citrate buffer (pH 7.0). The sample was 
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treated with RnaseA (0.25 mg/ml) overnight at 37 °C. Finally, the sample was re-
suspended in a 50 mM sodium citrate buffer (pH 7.0) containing 1 mM Sytox Green 
(Molecular Probes, OR), before it was evaluated by flow cytometry. To generate the 
DNA content histograms (the figure on p.61), the same number of cells (30,000) was 
collected for any given strain. 
 
Vacuole staining with CDCFDA 
 
Vacuole staining with CDCFDA (5-(and-6)-carboxy-2’, 7’-dichlorofluorescein 
diacetate), Molecular Probes) was performed based on the manufacturer’s instruction. 
Cells were grown in SC medium (Kaiser et al., 1994). In the exponential growth phase at 
a cell density of 5x106/ml, 106 cells were taken and re-suspended in 50mM sodium 
citrate buffered-SC medium, pH 5.1 µl of 10mM CDCFDA (in DMSO) was added and 
incubated for about 20 minutes at room temperature. The stained vacuoles were then 
evaluated with microscopy or flow cytometry. 
 
Vacuole purification 
 
Vacuole purification was performed based on the protocols by Roberts et al. and Conradt 
et al (Conradt et al., 1992; Roberts et al., 1991) . DKY6281 (pho8Δ) and BJ3505 (pep4Δ, 
prb1Δ) cells were grown in YPD medium. 4x1010 cells were collected from the 
exponential growth phase and washed with distilled water at room temperature. The cells 
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were pelleted and re-suspended in 100ml of 1M sorbitol, to which 1ml of Zymolyase 
solution (50mM Tri-HCl, pH 7.7, 1mM EDTA, 50% glycerol, 20mg (400 units)/ml 
Zymolyase 20T: ICN Immunobiologicals) was added and incubated with gentle shaking 
at 30oC for 90 minutes. Spheroplasts were collected by centrifugation at 2,200g for 5 
minutes and washed once with 1M sorbitol. The spheroplasts were broken by 
homogenizing (by pipetting) in 25ml buffer A (10mM 2-(MES)/Tris, pH 6.9, 0.1mM 
MgCl2, 12% Ficoll 400). The lysate was centrifuged at 2,200g for 10 minutes at 4oC. 
The supernatant was saved and transferred to Beckman SW 28 rotor and about 13ml of 
buffer A was overlayed. Then it was subjected to centrifugation at 60,000g for 30 
minutes at 4oC. The white wafer floating on top was collected with a spatula and 
homogenized in 6mL of buffer A. It was transferred to Beckman SW 41 Ti rotor and 
overlayed with 6ml buffer B (10mM MES/Tris, pH 6.9, 0.5mM MgCl2, 8% Ficoll 400) 
and centrifuged at 60,000g for 30 minutes at 4oC. Again, the white wafer floating on top 
was collected and re-suspended in 0.3ml of 2X buffer C (20mM MES/Tris, pH 6.9, 
10mM MgCl2, 50mM KCl). After homogenizing by pipetting, an equal volume of 1X 
buffer C was added. Vacuoles were aliquoted and stored at –80oC until use. Protein 
quantification was done to measure the concentration of purified vacuoles after 
solubilizing vacuoles with 2% SDS. 
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Cytosol preparation for in vitro vacuole fusion assay 
 
2 x 109 cells grown in SC medium till exponential growth phase were collected and 
washed with cold 0.25M sorbitol buffer (0.25M sorbitol, 20mM Pipes/KOH, pH 6.8, 
150mM potassium acetate, 5mM magnesium acetate). The cells were collected and re-
suspended in 200 µl of 0.25M sorbitol buffer with 1mM DTT and 0.5mM PMSF. Cell 
lysis was performed by bead beating of 10 cycles of 30 seconds vortex and 30 seconds 
chilling at 4oC. The lysate was clarified by sequential centrifugations at 3,000g for 5 
minutes at 4oC and 14,000g for 10 minutes at 4oC. Finally, the supernatant was 
centrifuged at 150,000g for 30 minutes at 4oC. The cytosol was aliquoted and quick 
frozen in liquid nitrogen and kept at –80oC until use. Protein quantity was measured as 
above. 
 
In vitro vacuole fusion assay 
 
The in vitro vacuole fusion assay was performed based on the procedure by Mayer et al 
(Mayer et al., 1996). The vacuole fusion reaction mixture was composed of 0.01mg/ml 
of purified vacuoles from pho8Δ and pep4Δ prb1Δ cells, 3.2 µl of 10X salt buffer 
(100mM Pipes/KOH. pH 6.8, 1M sorbitol, 50mM MgCl2, 1M KCl, 0.5M K-acetate), 
1.75 µl of 10X ATP-regenerating system (400mM creatine phosphate, 20mg/ml creatine 
phosphokinase, 10mM MgATP), 1~2mg/ml cytosol and 1X reaction buffer (20mM 
Pipes/KOH, pH 6.8, 0.3M sorbitol, 100mM KCl, 50mM K-acetate, 5mM MgCl2), filled 
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to a final overall volume of 33 µl. The reaction mixture was incubated at 27oC for 90 
minutes. To measure alkaline phosphatase (ALP) activity, 465 µl of assay reaction 
solution (250mM Tris/HCl, pH 8.0, 0.4% Triton X-100, 10mM MgCl2, 1mM pNPP (ρ-
nitro-phospho-phenol)) was added and incubated at 30oC for 5 minutes. ALP enzyme 
reaction was stopped by addition of 500 µl of termination solution (1M glycine/KOH, 
pH 11). Absorbance at 400nm was measured. This assay generated reliable results when 
comparing in vitro vacuole fusion activities among fusion reactions prepared from the 
same batch of reaction mixture. However, large deviations occurred when comparing in 
vitro vacuole fusion activities from different batches of reaction mixtures. Therefore, 
most relative fusion activities measured in this study were performed by comparing 
between fusion reactions with adding an inhibitor or buffer to an aliquot from the same 
batch of reaction mixture. In the experiment for the figure on p.71 to measure fusion 
activity the reaction mixture was equally split, and to each aliquot the same volume of 
buffer with inhibitor (or antibody) was added. Buffer-added aliquots were incubated at 
27 °C or on ice, the fusion activities of which were measured after 90 min and set as 
100% or 0% fusion activity, respectively. Inhibitor-added aliquot was incubated at 27 °C 
for the same time and its fusion activity was measured to evaluate the relative fusion 
activity. 
 For the immuno-depletion experiments, cytosolic extracts were incubated for 1 h 
at 4 °C with 60 µg of 12CA5 monoclonal anti-HA antibody prepared from ascites fluid, 
followed by an 1 h incubation at 4 °C with 50 µl of a protein G-Agarose bead solution 
(Pierce, IL). The beads were then removed and the cytosolic extracts were used in 
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vacuole fusion reactions as described above. Mock-depleted cytosols were prepared 
from the same batches of extracts but with the same volume of PBS instead of the anti-
HA antibody. The effects of each immunodepleted Cln (Cln2p or Cln3p) on the fusion 
activity were evaluated by comparing it to its mock-depleted counterpart. 
 
Vacuolar morphology and size 
 
For microscopic examination of vacuolar membranes the cells were stained with N-(3-
triethylammoniumpropyl)-4-(6-(4-diethylamino)phenyl)hexatrienyl)pyridinium 
dibromide, FM4-64 (Molecular Probes, Eugene, OR), and then examined 
microscopically with a Nikon Eclipse TS100 inverted fluorescence microscope. 
Vacuolar size was evaluated by flow cytometry after staining with the vital 
vacuolar stain 5’ (and 6’)- carboxy-2’,7’-dichlorofluorescein diacetate, CDCFDA 
(Molecular Probes, Eugene, OR). 
 
Budding index, DNA content, cell size and doubling time measurements 
 
The percentage of budded cells (budding index) was evaluated as described elsewhere 
(Zettel et al., 2003). DNA content was evaluated by flow cytometry as described 
previously (Bryan et al., 2004). The mean cell volume of live unfixed samples was 
measured using a Beckman Coulter® Z2 Channelyzer. The data were analyzed using the 
manufacturer’s AccuComp software. The geometric mean is indicated in each case. For 
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population doubling (generation) time measurements we used absorbance measurements 
at 600nm (A) at multiple time points (t) during the exponential growth of the culture. 
From the slope of the line obtained after plotting ln(A) vs. t, we got the specific growth 
rate constant of the culture (k). The culture’s doubling time (g) was then calculated from 
the formula g = ln2/k. 
  
Protein analysis 
 
Unless otherwise indicated, the gels for SDS-PAGE (Laemmli, 1970) contained 8% of a 
29:1 acrylamide/bis-acrylamide solution. For the immunoblots shown in the figure on 
p.55, cytosolic extracts were prepared as described above, while total cellular extracts 
were prepared as described previously (Kaiser et al., 1994), separated by SDS-PAGE on 
a 10% acrylamide gel, and transferred onto nitrocellulose. The blots were blocked in 
PBS containing 5% w/v dry non-fat milk and 0.1% v/v Tween-20. Between incubations 
the blots were washed three times 10 min each, in PBS. All the antibodies were added in 
blocking solution. The 12CA5 monoclonal antibody against HA was used at a 1:1,000 
dilution. The primary antibodies against yeast Prc1p (CPY), Pho8p (ALP) and Pgk1p 
were from Molecular Probes (OR), and they were used according to their instructions. 
Secondary antibody horseradish peroxidase conjugates were from Pierce (NJ) and used 
at 1:5,000 dilution. The blots were developed with chemiluminescent peroxidase reagent 
from Sigma, according to their instructions. 
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Immunoprecipitations and TEV cleavage of TAP-tagged Bem1p were performed 
according to the protocols and reagents recommended by Rigaut et al (Rigaut et al., 
1999). Briefly, 5x109 cells of untagged or TAP-tagged BEM1 cells from the exponential 
phase of growth were used. Cell extracts were prepared in the presence of protease and 
phosphatase inhibitor cocktails (Sigma, St. Louis, MO). After the first 
immunoprecipitation with IgG-agarose beads, the beads were washed twice with RIPA 
buffer and once with TEV reaction buffer. 80U of TEV for 30 min at 30 °C was used to 
cleave the protein A domain. The phosphatase experiment shown in the figure on p.77 
was done as described previously (Liakopoulos et al., 2003). For the phosphatase 
experiments in the figure on p.77, Bem1p-CBP on Calmodulin beads was washed three 
times with RIPA buffer and once with λ-phosphatase reaction buffer. Then 500U of λ-
phosphatase and 10x of protease inhibitor cocktail were added and incubated at 30 °C 
for 30 min in the presence or absence of 10x phosphatase inhibitor cocktail. 
For protein surveillance, cell extracts were prepared using a urea extraction 
buffer as described by Ubersax et al (Ubersax et al., 2003). The differences in Bem1p’s 
electrophoretic mobility in 1D SDS-PAGE are better resolved if the samples are desalted 
prior to electrophoresis (using a kit from Pierce (Rockford, IL), according to their 
instructions), and electrophoresis is performed at a constant voltage of 70V (instead of 
the typical 200V applied to mini-gels).  
2D gel electrophoresis was performed using carrier ampholytes (pH 4-6; GE 
Healthcare, UK) in acrylamide tubes according to the method of O’Farrell (O'Farrell, 
1975). 7 cm long tube gels containing 0.5% ampholytes were focused for approximately 
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1,000 volt hours without pre-focusing. The tubes were extruded and soaked, 
sequentially, in SDS sample buffer containing dithiothreitol or iodoacetamide. The tube 
gels containing the reduced and alkylated proteins were subsequently placed on top of 
8% polyacrylamide slab minigels and subjected to SDS PAGE (Laemmli, 1970). Prior to 
immunostaining, the proteins were electroblotted onto PVDF membranes (Immobilon 
Psq ; Millipore, MA) at 100 – 200 mAmps overnight using 10 mM CAPS, 10% methanol, 
pH 11. 
For immunostaining, protein A fusion proteins were detected with the 
Peroxidase-Anti-Peroxidase (PAP) soluble complex reagent from Sigma (St. Louis, 
MO). The anti-Pgk1p antibody was from Molecular Probes (Eugene, OR). The anti-
phospho [ST]P, anti-CBP, anti-HA and anti-Myc antibodies were from Abcam 
(Cambridge, MA). The horseradish peroxidase-conjugated secondary antibodies used for 
immunoblotting were also from Abcam (Cambridge, MA). All antibodies were used at 
the dilutions recommended by the manufacturers. The blots were processed with 
reagents from Pierce (Rockford, IL). 
 
Bacterial expression 
 
The pBAD-based plasmids were transformed into E. coli (strain XL1-Blue). For protein 
expression we followed previously published procedures (Guzman et al., 1995). From 
50-100 ml cultures we obtained soluble protein from all the constructs we describe here. 
The exception was Cln3p, which required larger cultures (0.5l-1l) because the majority 
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of the recombinant protein appeared to be insoluble. We purified the recombinant 
proteins through their 6xHis epitope, using TALON Co2+ affinity beads (BD 
Biosciences, CA), according to their instructions. 
 
Kinase assays 
 
Human Cdc2/cyclin B and Cdk2/cyclin A were from New England Biolabs (Beverly, 
MA), and used at 5U per reaction. Cln3p-associated activity was obtained from yeast 
cells (strain W303a) carrying plasmid BG1805-CLN3 (see Table 2.2), using TALON 
Co2+ affinity beads (BD Biosciences, CA), according to their instructions. The Cln3p-
associated activity was from ~1010 cells initially grown in raffinose, but 4h prior to 
harvesting the culture was induced with 2% galactose. Histone H1 was from Sigma (St. 
Louis, MO), and used as a substrate at 5 µg per reaction. Bem1p was obtained from 
bacteria as described above. The reactions also contained 5 µCi [γ-32P] ATP, 100 µM 
ATP, 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1mM EGTA, 2mM DTT and 0.01% Brij 
35. All the reactions (30 µl total volume) were performed at room temperature for 20 
min. 
 
Immunofluorescence microscopy 
 
Unless otherwise indicated, we followed the protocols of the Botstein lab as described at 
http://genome-www.stanford.edu/group/botlab/. 4'6-diamidino-2-phenylindole, DAPI, 
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was from Sigma (St. Louis, MO). The anti-tubulin primary antibody and the secondary 
FITC-conjugated antibody were from Abcam (Cambridge, MA). For the experiment 
shown in the figure on p.89, the cells were grown at 37 °C to exacerbate the bud 
emergence defect of bem1Δ cells. The samples were examined with a Nikon Eclipse 
TS100 inverted fluorescence microscope. 
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CHAPTER III 
THE G1 CYCLIN Cln3p CONTROLS VACUOLAR BIOGENESIS IN 
Saccharomyces cerevisiae 
 
Introduction 
 
Overall organelle morphology and copy number in proliferating cells remain constant, 
despite successive cell divisions. In yeast, as in animal cells, the enzymes that catalyze 
cell cycle transitions are complexes of a cyclin-dependent kinase (Cdk) and activating 
regulatory subunits called cyclins. In Saccharomyces cerevisiae, START is thought to 
represent a nodal point in late G1, where various aspects of the cell’s physiology are 
measured or monitored prior to initiation of DNA replication (Pringle and Hartwell, 
1981). START is brought about by the activity of Cdc28p (a Cdk) in association with 
one of the G1 cyclins, Cln1,2,3p (Wittenberg and Reed, 1996). Cells lacking all three 
CLN genes are inviable and cannot complete START (Richardson et al., 1989). During 
vegetative growth the only essential “collective” function of Clns is to promote the 
phosphorylation and subsequent proteolysis of the B-type cyclin kinase inhibitor Sic1p 
(Schneider et al., 1996; Tyers, 1996).  
None of the CLN genes alone, however, is necessary for the cell’s survival. This  
 
Reprinted with permission from “The G1 cyclin Cln3p controls vacuolar biogenesis in 
Saccharomyces cerevisiae” by Han, B.-K., Aramayo, R., and Polymenis, M., 2003, 
Genetics 165, 467-476. Copyright 2003 by the Genetics Society of America. 
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apparent redundancy has been challenged in the last few years, with Cln1,2p and Cln3p 
being functionally distinct. It is now thought that Cln3p functions upstream of Cln1,2p 
activating the G1/S transcription program (Dirick et al., 1995; Levine et al., 1996; Stuart 
and Wittenberg, 1995; Tyers et al., 1993), where >100 genes (CLN1,2 among them) are 
transcribed in a temporal manner at the G1/S transition (Spellman et al., 1998). 
Cln1,2p/Cdc28p complexes may regulate polarized growth during budding (Benton et 
al., 1993; Cvrckova and Nasmyth, 1993). They may also serve as upstream activators of 
the protein kinase C (Pkc1p), which is involved in cell wall biosynthesis (Heinisch et al., 
1999). Thus, it seems that Cln3p controls the correct timing of G1/S transcription, while 
Cln1,2p tethers G1/S progression with the morphogenetic and biosynthetic aspects of 
making a bud. 
The vacuole in Saccharomyces cerevisiae is a large compartment, occupying a 
significant fraction (~25%) of the total cellular volume (Wiemken and Durr, 1974). 
Vacuoles serve as repositories of metabolites and low molecular weight compounds and 
they are analogous to the lysosomes of animal cells, containing numerous hydrolases 
(Jones et al., 1997; Roberts et al., 1991). In all eukaryotic cells, the lysosomes or 
vacuoles play major cellular turnover roles, including autophagy where entire organelles 
are delivered to them for turnover (Klionsky and Emr, 2000). These lysosomal or 
vacuolar functions are evident during responses to stress or nutrient limitation, and also 
impact on developmental processes and human disease states (Klionsky and Emr, 2000). 
Vacuoles, as many other organelles (e.g. the Golgi), are not usually synthesized de novo 
in daughter cells, but instead they are inherited from mother cells. It is possible, 
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however, for a daughter cell to slowly synthesize a new vacuole (the same is true for the 
Golgi) if it did not inherit one (Catlett and Weisman, 2000). Since this is a slow and 
inefficient process, a vacuolar inheritance mechanism is believed to have evolved. 
Vacuolar morphology and inheritance is dynamic and is somehow coordinated with cell 
cycle progression (Catlett and Weisman, 2000). Yeast cells typically contain only one to 
three vacuoles, and their segregation to daughter cells follows an ordered pattern 
(Warren and Wickner, 1996). Beginning at the G1/S transition of the cell cycle, vesicles 
from the vacuole of the mother cell form a tubular structure and are transported into the 
newly formed bud, where they will eventually establish the vacuolar compartment of the 
daughter cell (Bryant and Stevens, 1998; Catlett and Weisman, 2000). However, it is not 
known whether the molecular machinery that regulates cell cycle progression also 
affects vacuolar inheritance and vice versa. 
Here we show that the G1 cyclin Cln3p regulates vacuolar biogenesis and 
segregation. Our findings suggest an unexpected role for a G1 cyclin that is specific to 
Cln3p and it is not shared by other G1 cyclins. 
 
Results 
 
Vacuolar morphology in cln3Δ cells 
To examine vacuolar morphology we first visualized the vacuoles with the vital 
amphiphilic styryl dye FM4-64 (see Materials and Methods), which stains the vacuolar 
membrane (Hill et al., 1996). The vacuolar compartment in about 60-70% of cln3Δ cells  
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FIGURE 3.1. Vacuolar fragmentation in cells lacking CLN3. Diploid cells of the indicated genotype (all 
in the BY4743 background) were exposed to FM4-64, a vital dye that stains the vacuolar membrane (see 
Materials and Methods), and photographed through phase optics (left panels) and by fluorescence 
microscopy with a rhodamine filter (right panels). 
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had a fragmented and multilobular appearance (Fig. 3.1). This was not the case, 
however, for cells lacking Cln1p and Cln2p (Fig. 3.1). The extent of vacuolar 
fragmentation was comparable to that of vac8Δ cells(Fig. 3.1), which are defective in 
vacuolar inheritance (Catlett and Weisman, 2000), and they display extensive vacuolar 
fragmentation (Wang et al., 2001). We also examined cells carrying the CLN3-2 allele, 
which effectively over-express Cln3p because they produce a truncated but stable form 
of the protein (Cross, 1988), but the vacuolar morphology of these cells was 
indistinguishable from wild-type cells (data not shown). Next, we evaluated wild-type 
and cln3Δ cells by electron microscopy (Fig. 3.2). Consistent with the fluorescence data, 
cells lacking Cln3p had more but smaller vacuoles (Fig. 3.2). We also observed 
extensive vacuolar fragmentation of cdc28-1 cells shifted to their non-permissive 
temperature (Fig. 3.3). This is consistent with the known role of Cln3p, as a regulatory 
subunit in a complex with Cdc28p important for the G1/S transition. These observations 
suggest that Cln3p, but not Cln1,2p, may be necessary for the maintenance of vacuolar 
morphology. 
The vacuolar compartment in cln3Δ cells occupied a significant portion of the 
cell (Figs. 3.1 and 3.2), and we decided to address this issue in more detail. We 
examined living cells carrying a wild-type (CLN3+), null (cln3Δ), or a dominant (CLN3-
2) CLN3 allele. The cells were stained with a vacuolar fluorescent probe, 5-carboxy-
2’,7’-dichlorofluorescein diacetate (CDCFDA). CDCFDA is localized in the vacuole by 
diffusion, where it is hydrolyzed into an impermeant fluorescent anionic derivative 
(Preston et al., 1989). The cells were then examined either by fluorescence microscopy 
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FIGURE 3.2. Electron micrographs of wild-type and cln3Δ cells. V indicates the vacuole. 
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FIGURE 3.3. Vacuolar fragmentation in cdc28-1 cells. Wild-type and cdc28-1 cells (in the A364A 
background, see Materials and Methods) were exposed to FM4-64 and photographed through phase optics 
(left panels) and by fluorescence microscopy with a rhodamine filter (right panels). The cells were 
photographed both during growth at room temperature and after they were shifted for 6 h to 37 ºC, the 
non-permissive temperature of the cdc28-1 strain (see Materials and Methods). 
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(Fig. 3.4A) or flow cytometry (Fig. 3.4B). CDCFDA-fluorescence intensity, representing 
vacuolar size, of live cells was quantified by flow cytometry (Fig. 3.4B) from the same 
samples that were used to obtain the forward angle scattering cell size estimates, to 
simultaneously obtain both parameters. Note that this analysis confirmed the expected 
small vacuolar compartment of pep3Δ cells (Table 3.1), which are known to have small 
vacuolar vesicles (Preston et al., 1991). In Table 3.1, we summarize the values of cell 
size and vacuolar size in CLN3+, cln3Δ and CLN3-2 cells in the BY4741 background. 
Importantly, we noticed disparities in vacuolar size that did not correlate with cell size 
differences. For example, cln3Δ cells are 30% larger overall than CLN3+ cells, but their 
vacuole is 80% larger. This disproportional enlargement of the vacuolar compartment in 
cln3Δ cells was evident (P<0.05, based on a Student’s t test) in all strains tested, 
irrespective of ploidy, haploid BY4741 vs. diploid BY4743, and genetic background, 
strains BY4741 vs. W303, (data not shown). Note that the above differences in vacuolar 
volume were not due to intra-vacuolar pH differences which may alter the fluorescence 
of the vacuolar probe we used, for two reasons: First, both cln3Δ and CLN3-2 cells had a 
vacuolar pH in the same range as wild-type cells (≥ 5.98 and ≤ 6.14; data not shown). 
Second, the vacuolar size differences were evident even after the intra-vacuolar pH was 
equilibrated to that of external buffers (data not shown). 
 We also estimated cell size and vacuolar size using confocal microscopy. For 
CLN3+, cln3Δ, and CLN3-2 haploid cells in the BY4741 strain background, cultured in 
defined SC media, the relative cell volume values were 1±0.24 (n=20), 1.35±0.35 
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FIGURE 3.4. Cell and vacuole size in cells carrying different CLN3 alleles. All the strains shown were in 
the haploid BY4741 background. A, Cells were photographed through phase optics (left panels) and by 
fluorescein fluorescence (right panels) to visualize the vacuole of exponentially growing cells in rich 
defined SC media (see Materials and methods). B, Cell volume of the indicated strains was measured 
using a Channelyzer (left panels), or flow cytometry by forward angle scattering (FSC, middle panels). 
Vacuolar fluorescence was measured by flow cytometry (right panels). In every panel, the measured 
parameter is shown on the x-axis, and the number of cells on the y-axis. The geometric mean is shown in 
each case. 
 
 
 
 
 
 
 
  
53  
 
 
 
TABLE 3.I. Loss of Cln3p disproportionately enlarges the vacuole 
              Relative cell sizea Strain 
Channelyzer FSC 
         Relative 
       vacuolar size 
CLN3+ 1±0.06 (4) 1±0.05 (5) 1±0.09 (5) 
Cln3Δ 1.35±0.17 (4) 1.53±0.06 (5) 1.92±0.19 (5) 
CLN3-2  0.68±0.05 (4) 0.63±0.02 (7) 0.51±0.06 (7) 
Cln2Δ 1.07±0.02 (6) 2.13±0.04 (4) 0.96±0.17 (4) 
Cln1,2Δ 1.59±0.16 (6) 1.42±0.06 (3) 0.80±0.06 (3) 
Pep3Δ 0.84±0.06(20) 0.92±0.03 (3) 0.45±0.04 (3) 
 
aMeans and standard deviations of standardized values are shown. The number in parentheses indicates 
independent cultures analyzed in each case. For cell and vacuolar size the geometric mean is used. For the 
CLN3-2 plasmid-transformed strain the cultures examined were from independent transformants and 
compared to the parental strain transformed with an empty low-copy centromeric plasmid. The cellular 
parameters of the parental strain transformed with the empty low-copy vector were similar to those of the 
un-transformed strains (not shown). All the strains were grown in synthetic SC media. 
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(n=23), and 0.71±0.19 (n=20), respectively. In contrast, the vacuolar size of CLN3+, 
cln3Δ, and CLN3-2 cells, relative to the overall cell size of wild-type cells was 
0.25±0.13 (n=40), 0.55±0.17 (n=50), and 0.14±0.07 (n=22), respectively. Our results are 
in very good agreement with earlier estimates of vacuolar size (25% of total cellular 
volume)(Wiemken and Durr, 1974), and our own data regarding the relative vacuolarand 
cell size parameters in cln3Δ cells we reported above (Table 3.1).  
However, the vacuolar size in cells that lack another G1 cyclin, Cln2p, was not 
significantly affected (Table 3.1). Even in cells that lacked both CLN1 and CLN2 and 
were quite large overall, the vacuole was not disproportionately enlarged. Instead, we 
noticed a decrease in vacuolar size in cln1,2Δ cells (Table 3.1). Thus, based on our 
results with the cln1,2Δ strain, we conclude that a decrease in vacuolar size is not 
necessarily accompanied by overall cell size decrease. Specifically in the case of cln3Δ 
cells, however, loss of Cln3p clearly increases the size of the vacuolar compartment to a 
greater extent than what was predicted from cell size differences. 
 
Cells that lack Cln3p are defective in vacuole homotypic fusion 
Given the fragmented vacuolar morphology of cln3Δ cells, we then decided to test 
Cln3p’s effects in an in vitro vacuole homotypic fusion assay developed by Wickner and 
colleagues (Wickner and Haas, 2000). The process of vacuole vesicle fusion is crucial in 
determining the overall vacuole copy number and vacuolar biogenesis in general 
(Wickner and Haas, 2000). Vacuoles were purified and then mixed in the presence of 
cytosol and ATP. To evaluate vacuole fusion microscopically (Fig. 3.5A), the fused  
  
55  
 
 
 
FIGURE 3.5. Cln3p regulates vacuole homotypic fusion in vitro. A and B, Purified vacuoles were allowed 
to fuse in the presence of ATP and cytosol and stained with CDCFDA, before they were photographed. A, 
vacuole fusion in the presence of cytosol prepared from the indicated strains, all in the BY4743 
background. To visualize the vacuoles in the absence of ATP and cytosol (lower right panel), we exposed 
for 30 sec, because shorter exposures were insufficient. In contrast, fused vacuoles, in the presence of ATP 
and cytosol, fluoresce much more intensely, so for wild-type cytosol (upper left panel) we exposed for 6 
sec, while for CLN3-2 cytosol (lower-left panel) the fluorescence was so intense that the exposure was 
only 4 sec. For cln3Δ cytosol (upper right panel), or for the no cytosol control (middle right panel), we 
exposed for 10 sec. Aliquots of the vacuole fusion reactions shown were evaluated colorimetrically, based 
on the reconstitution of alkaline phosphatase activity. The average and standard deviations from at least 
seven independent experiments of relative alkaline phosphatase activity, normalized for background (no 
cytosol), obtained from the indicated reactions is shown. B, vacuole fusion in the presence of cytosol from 
untagged, CLN2-HA, or CLN3-HA tagged strains. All the cytosols were immuno-depleted using an anti-
HA monoclonal antibody (see Materials and Methods) before they were used in the vacuole fusion 
reactions. The precipitated (P) and the supernatant (S) fractions were evaluated by immunobloting using 
the anti-HA antibody, to measure the extent of cyclin depletion. (*) indicates non-specific bands. Fusion 
was evaluated microscopically, and the exposure time was the same (10 sec) for all the photographs 
shown. Aliquots of the vacuole fusion reactions shown were also evaluated colorimetrically, based on the 
reconstitution of alkaline phosphatase activity. The average and standard deviation from three independent 
experiments of relative alkaline phosphatase activity, normalized for background (no cytosol), obtained 
from the indicated reactions is shown. C, The intracellular steady-state levels of Pgk1p and the pro- and 
mature (m) forms of CPY and ALP in cells of the indicated genotype were evaluated by immunobloting. 
The pep4Δ, prb1Δ strain was BJ3505 (see Methods), while all the others were in the BY4743 background. 
D, Homotypic fusion reactions using cytosol from CLN3+ and cln3Δ cells (in the BY4743 background) 
transformed with an empty (vector) or CLN2-containing (CLN2) high copy plasmid, were evaluated 
colorimetrically as described above. The average and standard deviations from four independent 
experiments of relative alkaline phosphatase activity, normalized for background (no cytosol), obtained 
from the indicated reactions is shown. 
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vacuoles were stained with CDCFDA. Cytosol from cells lacking Cln3p had 
significantly reduced fusion activity (Fig. 3.5A). The extent of vacuole fusion can also 
vacuoles were stained with CDCFDA. Cytosol from cells lacking Cln3p had 
significantly reduced fusion activity (Fig. 3.5A). The extent of vacuole fusion can also 
be evaluated colorimetrically, because the purified vacuoles in this assay were prepared 
from two different strains, each lacking the ability to produce active alkaline 
phosphatase (encoded by PHO8). One of the strains lacks PHO8, while the other lacks 
vacuolar proteases necessary for Pho8p maturation. In this assay, processed vacuolar 
alkaline phosphatase can be produced only if the vacuolar constituents from the two 
strains mix after fusion (Wickner and Haas, 2000). Although the enzymatic assay was 
not as sensitive as the direct microscopic observation, it was still clear that alkaline 
phosphatase activity, which reflects vacuole fusion, was lower (P<0.05, based on a 
Student’s t-test) in the presence of cytosol from cln3Δ cells (Fig. 3.5A). 
 To more directly test the role of Cln3p in vacuolar homotypic fusion, we 
prepared cytosol from wild-type cells, and from cells carrying epitope-tagged versions of 
Cln2p (CLN2-HA) and Cln3p (CLN3-HA). These epitope-tagged Cln2p and Cln3p are 
fully functional (Tyers et al., 1993; Tyers et al., 1992). Cytosol from the untagged and 
tagged strain was incubated with either an antibody against the epitope for 
immunodepletion, or mock-depleted with PBS, and we then carried out 
immunoprecipitations, to deplete the HA epitope-carrying polypeptides from the 
cytosolic extracts. The extent of immunodepletion was significant (>90%), as shown on 
the immunoblot below the micrographs on Fig. 3.5B. The immuno-depleted or mock-
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depleted cytosolic extracts were then evaluated for vacuole homotypic fusion activity 
(Fig. 3.5B). It is clear that depletion of Cln3p, but not Cln2p, reduced homotypic fusion 
activity (Fig. 3.5B). These results further strengthen the notion that Cln3p is required for 
homotypic fusion activity. 
 To test whether CLN3 deletion or over-expression might somehow affect 
secretory pathways of vacuolar protein sorting (Jones et al., 1997), we evaluated the 
maturation of two vacuolar enzymes, carboxypeptidase Y (CPY) and vacuolar 
membrane alkaline phosphatase (ALP), in CLN3+, cln3Δ and CLN3-2 cells (all in the 
BY4743 background). The CPY precursor, Prc1p, traffics through the ER, Golgi, and 
pre-vacuolar compartments before it is sorted to the vacuole (Jones et al., 1997). ALP 
bypasses the pre-vacuolar compartment. We found that steady-state levels of mature 
CPY and ALP was similar among wild-type, cln3Δ and CLN3-2 cells (Fig. 3.5C). Thus, 
it does not appear that the secretory processes that are involved in CPY and ALP 
maturation are grossly affected in CLN3-2 or cln3Δ cells. 
Finally, increasing the dosage of another G1 cyclin, CLN2, could not suppress 
the defect in homotypic fusion observed in cln3Δ cells (Fig. 3.5D). We also examined 
vacuolar morphology of these cells after staining with the vacuolar membrane stain 
FM4-64, and we found that the vacuolar fragmentation of cln3Δ cells we described 
above (Fig. 3.1), was not rescued by introducing CLN2 on a high-copy plasmid (data not 
shown). 
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Cln3p and vacuolar segregation 
After examining photographs of budded cln3Δ cells we noticed that in several cases the 
signal associated with the vacuolar compartment was not equally distributed between the 
bud and the mother cell (Fig. 3.6A). This is different from wild-type cells, which 
distribute their vacuoles between the mother and the bud. In the known vacuolar 
inheritance mutants the bud fails to receive vacuoles, as was evident in vac8Δ cells (Fig. 
3.6A). Note that the vacuoles stained by FM4-64 do not represent all the vacuoles in the 
cell, because between the time of staining and the time of observation, new vacuoles are 
synthesized in the cell, which are not stained (see Materials and Methods). We were 
particularly surprised to find that there was also a fraction of cln3Δ cells that distributed 
their vacuoles almost exclusively in the bud and not in the mother (Fig. 3.6A and B). 
This has not been observed in known vac mutants. 
 
VAC8 and CLN3  
We next examined vacuolar morphology and cell cycle progression of cells mutant for 
VAC8 and CLN3 (Fig. 3.7). Combined loss of CLN3 and VAC8 does not lead to an 
apparent additive effect and the cells still have visible but fragmented vacuoles. In 
addition, over-expression of CLN3 in vac8Δ cells, and vice versa, does not suppress the 
vacuolar fragmentation defects of the singly mutant strains either (Fig. 3.7). Thus, it does 
not appear that CLN3 and VAC8 function in a simple linear pathway. 
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FIGURE 3.6. Cells lacking CLN3 are defective in vacuolar segregation. Cells of the indicated genotype 
(all in the BY4743 background) were stained with FM4-64 to visualize vacuole membranes. A, Random 
fields of cells were examined for vacuolar segregation, 2 h after vacuolar staining with FM4-64 (see 
Materials and Methods). The number of cells examined is shown in parentheses. The scored cells were 
grouped into two groups based on bud size, and within each group the percentage of cells with the 
indicated vacuolar morphology is shown. B, Unequal vacuolar segregation in homozygous diploid cln3Δ 
cells, stained and photographed as described in the legend of Fig. 3.1. 
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FIGURE 3.7. CLN3 and VAC8 in vacuolar biogenesis and cell cycle progression. Cells of the indicated 
genotype (all in the BY4741 background) were exposed to FM4-64 and photographed through phase 
optics (left panels) and by fluorescence microscopy with a rhodamine filter (middle panels). Their cellular 
DNA content (right panels) was determined by FACS. For each strain, the percentage of cells in G1, 
calculated by the ModFit software, is indicated. Cell numbers are plotted on the y-axis and the x-axis 
represents fluorescence. 
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We also examined cell cycle progression of these strains by flow cytometry (Fig. 
3.7, right panels). Note that vac8Δ cells proliferated at the same rate as wild-type or 
cln3Δ cells (data not shown). Interestingly, in vac8Δ cells there was an increase in  
the percent of cells in the G1 phase of the cell cycle. Thus, as is the case for cln3Δ cells 
(Cross, 1988; Nash et al., 1988), it appears that vac8Δ cells stay longer in G1 but there is 
a compensatory shortening of subsequent cell cycle phases, resulting in no net change in 
doubling time. Over-expression of Vac8p had no effect on cell cycle progression (data 
not shown). Importantly, however, Cln3p over-expression in vac8Δ cells accelerated 
completion of START, without suppressing the vacuolar fragmentation of these cells 
(Fig. 3.7), suggesting that, at least in this case, vacuolar fragmentation is not necessarily 
linked to the timing of START. Taken together, our results indicate that Cln3p’s role in 
vacuolar biogenesis is distinct from that of Vac8p and also separate from Cln3p’s 
established function in G1/S progression. 
 
Discussion 
 
Besides the chromosomes in the nucleus, the size and copy number of all organelles 
must also be maintained during cell proliferation. This work documents a novel role for 
a eukaryotic G1 cyclin in vacuolar (lysosomal) homeostasis, suggesting that the same 
cell cycle machinery that initiates cell division may also perform a separate function in 
the control of vacuolar biogenesis and segregation. 
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There are usually 1-3 vacuoles per cell (Warren and Wickner, 1996). In cln3Δ 
(but not cln1Δ and/or cln2Δ) cells, the vacuolar compartment was fragmented (Fig. 3.1 
and 3.2). Interestingly, the overall vacuolar compartment of cln3Δ cells was 
disproportionately enlarged (Fig. 3.4). Even though vacuole size does not always dictate 
overall cell size (for example, cln3Δ and cln1,2Δ cells are both large but the size of their 
vacuolar compartment differs by 3-4 fold, see Table 3.1), this result underscores the 
complexity of cell size regulation. Organelle contribution to overall cell size is not 
usually taken into consideration in studies of cell size control. How could Cln3p regulate 
vacuolar biogenesis? We provide evidence that Cln3p controls vacuolar homotypic 
fusion activity in vitro (Fig. 3.5). These findings raise the issue of Cln3p’s sub-cellular 
localization. Cln3p is certainly found in the nucleus (Miller and Cross, 2000), but a more 
recent report clearly showed that Cln3p is also found in the cytoplasm (Gari et al., 2001). 
Note also that cytosolic extracts immuno-depleted for Cln3p could not support 
homotypic fusion (Fig. 3.5), arguing for a post-translational mechanism of regulation of 
homotypic fusion by Cln3p. Whether Cln3p needs to exit the nucleus or simply acts on a 
nuclear factor which then exits the nucleus is unclear at present, since our cytosolic 
preparations are not devoid of soluble nuclear proteins. Since forcing Cln3p in the 
cytoplasm leads to cell size enlargement (Edgington and Futcher, 2001), and since we 
show here (Fig. 3.4) that the large size of cln3Δ cells is largely due to vacuolar 
enlargement, it is perhaps likely that Cln3p still functions in the nucleus where it perhaps 
modifies a factor that in turn exits into the cytoplasm and affects vacuolar biogenesis. In 
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any case, it is clear that Cln3p’s function in vacuolar biogenesis is separate from its 
established role in activating the G1/S transcriptional program. 
Self (homotypic) fusion of organelle vesicles is essential for organelle 
homeostasis (Wickner and Haas, 2000). In animal cells, inhibition of Golgi homotypic 
fusion in mitosis results in extensive fragmentation of the Golgi. This is important for 
Golgi inheritance because the resulting Golgi vesicles stochastically disperse in equal 
numbers in both daughter cells where, after completion of mitosis, they will fuse to re-
generate the Golgi (Warren and Wickner, 1996). Warren and colleagues have shown that 
mitotic inhibition of Golgi homotypic fusion is mediated by the cyclin-dependent kinase 
Cdc2 (Lowe et al., 1998; Nelson, 2000). Is it possible that aspects of this established 
paradigm also operate in Cln3p’s role during vacuolar biogenesis? Perhaps. Note that 
while the Cln3p/Cdc28p complex may be necessary for high vacuolar homotypic fusion 
activity, the mammalian Cdc2/cyclinB complex does the opposite, because it inhibits 
Golgi vesicle fusion. Overall, however, we think it is intriguing that, although in each 
case different organelles are affected at different cell cycle points, in both cases 
organelle homotypic fusion may be sensitive to changes in the activity of cyclin/Cdk 
complexes. 
Loss of Cln3p not only affects vacuolar morphology, but it also impacts on 
vacuolar segregation (Fig. 3.6). To our knowledge, this is the first evidence linking a cell 
cycle regulator with vacuolar segregation. Overall, how do the vacuolar phenotypes of 
cln3Δ cells compare to those of other vacuolar mutants? We think that although cln3Δ 
cells share some characteristics with other vacuolar mutants, the combination of these 
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characteristics makes them unique. For example, vacuolar enlargement and a 
concomitant overall cell enlargement are evident in fab1 mutants (Gary et al., 1998; 
Jorgensen et al., 2002). But, in contrast to cln3Δ cells, the vacuole of fab1 cells is not 
fragmented, fab1 cells lose vacuolar acidity, and vacuolar protein sorting is impaired as 
well (Gary et al., 1998). During the course of this work, the fragmented vacuole of cln3Δ 
cells was also mentioned in a genome-wide study of vacuolar morphology (Seeley et al., 
2002). The fragmented vacuolar morphology of cln3Δ cells corresponds to class B 
vacuolar protein sorting (vps) mutants, and is apparently similar to vac8Δ cells (Seeley et 
al., 2002). Furthermore, both Vac8p (Wang et al., 2001) and Cln3p (Fig. 3.5) appear to 
be required in vacuole fusion. However, based on our results, we think there are 
important differences between vac8Δ and cln3Δ cells. For example, note that in vac8Δ 
cells vacuolar fragmentation is not accompanied by overall vacuolar and cellular 
enlargement (see Figs. 3.1 and 3.6). Furthermore, our analysis of double CLN3 and 
VAC8 mutants argues against a simple linear relationship of the two gene products in 
vacuolar biogenesis (Fig. 3.7). In known vac mutants (including vac8Δ cells), it is the 
daughter cells that do not receive enough vacuoles (Catlett and Weisman, 2000). 
However, in cln3Δ cells it appears that at least in some cases the opposite is true (Fig. 
3.6). Although known vac mutants are not defective in vacuolar retention, retention in 
the mother cell can play an important role during organelle partition, and it is an 
established aspect of mitochondria segregation in yeast (Yang et al., 1999). Finally, loss 
of Vac8p apparently delays the G1/S transition (Fig. 3.7), but it is not clear at this point 
whether vacuolar biogenesis can causally alter cell cycle progression. Note that vacuolar 
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fragmentation per se in vac8Δ cells is not blocking acceleration of START in the context 
of the dominant CLN3-2 allele (Fig. 3.7). 
Based on the results we report here, it appears that the seemingly separate events 
of the nuclear cell division cycle and the cytoplasmic processes that control organelle 
segregation might be controlled by separate functions of the same machinery. Our 
finding that Cln3p is involved in vacuolar biogenesis at least provides a handle towards a 
more detailed understanding of these phenomena in yeast. Since regulatory mechanisms 
of cell division and organelle biogenesis are highly conserved between yeast and 
humans, findings from yeast studies should be relevant to these processes in other 
organisms. 
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CHAPTER IV 
Bem1p, A SCAFFOLD SIGNALING PROTEIN, MEDIATES CYCLIN-
DEPENDENT CONTROL OF VACUOLAR HOMEOSTASIS IN Saccharomyces 
cerevisiae 
 
Introduction 
 
Overall cell size and macromolecular composition remain unaffected after successive 
rounds of cell division. This phenomenon also extends to intracellular membrane-bound 
organelles, because the copy number and size of any given organelle compartment 
remain constant in dividing cells (Shorter and Warren, 2002; Warren and Wickner, 
1996). Implicit in this central aspect of cellular physiology is a tight coordination 
between cell division and organelle biogenesis, but in most cases the mechanisms remain 
mysterious (Shorter and Warren, 2002; Warren and Wickner, 1996). 
Vacuoles in Saccharomyces cerevisiae serve as repositories of metabolites and 
low molecular weight compounds and are analogous to the lysosomes of animal cells, 
containing numerous hydrolases (Jones et al., 1997; Roberts et al., 1991). The vacuole is 
a low-copy organelle, and yeast cells typically contain 1-3 vacuoles. The large size of 
the vacuolar compartment {~25% of the total cellular volume (Wiemken and Durr, 
1974)} and the availability of vacuole-specific vital fluorescent dyes facilitate 
observations of overall vacuolar morphology. Defects in self (homotypic) fusion of 
vacuolar vesicles lead to vacuolar fragmentation (Seeley et al., 2002). Thus, homotypic 
fusion is very important for vacuolar homeostasis and it can also be evaluated in vitro 
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(Wickner and Haas, 2000). Although daughter cells of certain vacuolar inheritance 
mutants can be born without a vacuole, they must form a new one before they can pass 
through a point in late G1 called START and initiate DNA replication and a new round 
of cell division (Weisman, 2003). A recent report also suggested that in Candida 
albicans the vacuolar compartment may impact on cell cycle progression and hyphal 
development (Barelle et al., 2003). Nonetheless, it is not known how the molecular 
machinery that regulates cell cycle progression also affects vacuolar biogenesis or vice 
versa. 
In late G1, START completion is mediated by Cdc28p (a cyclin-dependent 
kinase, CDK) in association with one of the G1 cyclins, Cln1,2,3p. Cells lacking all 
three CLN genes are inviable and cannot complete START (Richardson et al., 1989). 
Cln3p functions upstream of Cln1,2p activating the G1/S transcription program (Dirick 
et al., 1995), where ~200 genes (CLN1,2 among them) are transcribed (Spellman et al., 
1998). Cln3p/Cdc28p phosphorylates Whi5p, a repressor of the G1/S transcription factor 
SBF, thereby releasing Whi5p from SBF and activating START transcription (Costanzo 
et al., 2004; de Bruin et al., 2004; Schaefer and Breeden, 2004). In addition, our earlier 
findings provided evidence for a novel function of Cln3p in vacuolar homotypic fusion, 
separate from its role in G1/S transcription and not shared by other G1 cyclins (see 
CHAPTER II). 
A central polarity-establishment factor in a variety of organisms (from yeast to 
humans) is Cdc42p, a Rho-type small GTPase that orchestrates numerous processes 
necessary for polarization, such as septin and actin organization and membrane 
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trafficking, in response to cell cycle transitions and environmental cues (Etienne-
Manneville, 2004; Irazoqui and Lew, 2004). Cdc42p membrane localization is not 
restricted to the plasma membrane but includes internal membranes, notably vacuolar 
membranes (Richman et al., 2004). Furthermore, Cdc42p is one of several GTPases 
required for vacuolar homotypic fusion (Eitzen et al., 2001; Muller et al., 2001). 
Reorganization of vacuole-bound actin is needed for vacuolar homotypic fusion, and 
proteins of the Cdc42p-dependent processes necessary for actin remodeling are enriched 
on vacuolar membranes (Eitzen et al., 2002). Among numerous Cdc42p effectors and 
interacting proteins, the scaffold protein Bem1p is critical for proper Cdc42p activation 
(Irazoqui et al., 2003). After the Cln3p/Cdc28p-mediated initiation of the G1/S 
transcription program, the burst of late G1 phase Cdk activity involving Cln1,2p/Cdc28p 
and Pcl1,2p/Pho85p (another cyclin/Cdk complex) triggers a pathway that leads to 
phosphorylation of Cdc24p. Cdc24p is a Cdc42p guanine nucleotide exchange factor 
(GEF). Once at the bud site, Cdc24p binds Bem1p and Cdc42p-dependent actin 
reorganization necessary for bud emergence takes place (Bose et al., 2001; Gulli et al., 
2000; Moffat and Andrews, 2004). 
In this report, we show that Bem1p is required for vacuolar homotypic fusion and 
that the overall vacuolar compartment in bem1Δ cells is enlarged but fragmented, similar 
to cln3Δ cells. Furthermore, Bem1p is phosphorylated in a Cln3p-dependent manner at 
Ser72. A single S72D substitution in Bem1p (which mimics phosphorylation), or over-
expression of CDC42 or CDC24 suppresses the vacuolar fragmentation of cln3Δ cells. 
Conversely, substituting Ser72 in Bem1p with Ala blocks the ability of Cln3p to 
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promote vacuole fusion, in vivo and in vitro. The results we report here suggest that 
Cln3p impacts on vacuolar homeostasis through Bem1p and Cdc42p. 
 
Results 
 
Cln3p is required for an early step of vacuolar homotypic fusion 
We had previously shown that Cln3p is required for vacuolar homotypic fusion 
(CHAPTER II). Vacuolar homotypic fusion is composed of several distinct sequential 
steps: Priming, docking, and fusion (Wickner and Haas, 2000). To study the kinetics of 
the reaction, order of addition experiments can be done, whereby the fusion reaction 
progressively becomes resistant to the addition of various inhibitors, once the inhibitor-
sensitive step has been completed. For example, placement on ice blocks all steps and 
thus results in a “late-stage” inhibition profile, which is also similar to the GTP-γ-S 
inhibition profile. There are several GTPases involved in more than one step, including 
the last fusion step, which leads to a “late-stage” inhibition profile by GTP-γ-S (Eitzen et 
al., 2001; Eitzen et al., 2000). On the other hand, the ionophore FCCP blocks the 
docking step and it does not significantly inhibit the overall reaction if added late. 
Using this approach, we decided to determine the stage of the overall reaction that 
requires Cln3p for its completion, with cytosol from cells expressing HA-tagged Cln3p. 
We then added an anti-HA antibody as an inhibitor at various time points during the 
reaction, and measured the overall fusion activity at the end of the 90 min incubation 
period (Fig. 4.1). This experiment was done in parallel with several other reactions, to  
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Figure 4.1. Cln3p is required for an early step during vacuole fusion. A, A schematic of the experimental 
strategy is shown. B, Fusion reactions were incubated at 27°C with cytosol from a CLN3-HA strain. At the 
indicated times of addition (t1) shown on the x-axis, aliquots were removed and added to tubes containing 
anti-HA Ab, FCCP, GTP-γ-S, or buffer and incubated at 27°C. The activity from the buffer-containing 
tube at 27°C was set as 100% fusion activity. Another buffer-containing tube was incubated on ice and its 
activity was set at 0% fusion activity. As a control, aliquots of reactions with cytosol from the untagged 
isogenic strain were also added at various time points to tubes containing the anti-HA Ab (●) or buffer, 
and treated in the same manner as above. Reactions were incubated for a total of 90 min and then assayed 
for alkaline phosphatase, the relative values of which are shown on the y-axis. C, Fusion reactions were 
performed as described in Materials and Methods, using cytosol from cln3Δ cells and recombinant 
proteins from bacteria as indicated. Fusion was evaluated colorimetrically and the average and standard 
deviation of the relative fusion activities from at least three independent experiments is shown. 
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compare the profile of Cln3p withdrawal to the profiles of known fusion inhibitors (Fig. 
4.1). From this analysis, it appears that the reaction becomes resistant to removal of 
Cln3p with kinetics slightly earlier than the kinetics for FCCP addition (Fig. 4.1). Thus, 
once docking is complete, Cln3p is not required for vacuolar homotypic fusion. 
To further test whether the requirement for Cln3p in vacuole fusion is direct, and 
not somehow due to indirect effects resulting from Cln3p’s role in G1/S transcription, 
we performed the in vitro fusion reaction using cytosol from cln3Δ cells, supplemented 
with Cln3p expressed in bacteria (Fig. 4.1C). Addition of recombinant Cln3p, but not of 
the unrelated control protein Dcr2p (Pathak et al., 2004), increased fusion activity (Fig. 
4.1C). These results argue that there is a direct requirement for Cln3p in vacuole fusion.  
 
Bem1p impacts on vacuolar biogenesis, downstream of Cln3p 
To understand Cln3p’s vacuolar function, we reasoned that one of the numerous known 
regulators of homotypic fusion might be targeted by Cln3p. Possible downstream 
effectors of Cln3p/Cdc28p in vacuolar homotypic fusion may display the following 
properties: loss of function mutations should lead to vacuolar and overall cell size 
enlargement; loss of function mutations should lead to vacuolar fragmentation; and the 
putative effectors should be Cdk targets. Recent genome-wide studies focused on these 
properties, namely altered cell size (Jorgensen et al., 2002; Zhang et al., 2002); 
fragmented vacuolar morphology (Seeley et al., 2002); and proteins that are 
phosphorylated by Cdc28p in whole-cell extracts (Ubersax et al., 2003). There are more 
than a hundred gene products in each data set (Fig. 4.2A). For example, there were 181  
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Figure 4.2. Bem1p is required for vacuole fusion and vacuolar size homeostasis. A, Venn diagrams from 
the indicated genome-wide studies, with the number of genes corresponding to different phenotypes in 
each case is shown. B, Vacuole fusion using cytosol from untagged, CLN2-TAP, or BEM1-TAP tagged 
strains (see Table 2.1), carried out in the presence of rabbit IgG antibody. Each measurement was 
evaluated upon addition of rabbit IgG or buffer. The buffer-containing reactions were then incubated at 
27°C or ice (setting the 100% and 0% values of fusion activity). The IgG-containing reactions were 
incubated at 27°C. Fusion was evaluated colorimetrically and the average and standard deviation from at 
least three independent experiments is shown. C, Cell and vacuole size of live CDCFDA-stained BEM1+ 
and bem1Δ cells (in the diploid BY4743 background) was evaluated by flow cytometry. The number of 
cells is shown on the y-axis, and the x-axis indicates forward angle scattering, which is indicative of cell 
size (FSC), or vacuolar fluorescence (FL). The average and standard deviation from five independent 
measurements in each case is shown. 
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proteins that were significantly phosphorylated by Clb2p/Cdc28p (with a P-score ≥2, 
which is the logarithm of the amount of phosphate incorporated per ng of protein). Yet, 
only Cln3p itself and Bem1p were present in all three data sets (Fig. 4.2A). 
Using the in vitro fusion assay, we found that reactions with cytosol from BEM1-
TAP cells in the presence of inhibitory rabbit IgG (which targets the TAP domain) had 
significantly reduced fusion activity (Fig. 4.2B). Loss of Bem1p or Cln3p also leads to 
vacuolar fragmentation in about 40-60% of the cells {see Figs. 4.2-4.3A,B and (Han et 
al., 2003; Seeley et al., 2002)}. Furthermore, cells lacking BEM1 were larger overall 
(~40%, Figs. 4.2, 4.3) than wild-type cells and, importantly, their vacuolar compartment 
was also disproportionately enlarged (about 2-fold, Figs. 4.2, 4.3). Finally, Cdc28p 
readily phosphorylated Bem1p (P-score =4.4) in the phosphorylation assays by Ubersax 
et al (Ubersax et al., 2003). Consequently, we decided to evaluate Bem1p as a putative 
Cln3p/Cdc28p effector in vacuolar biogenesis.  
 To test whether Cln3p might mediate its effects in vacuolar biogenesis through 
Bem1p, we measured the overall cell size and vacuolar size of CLN3 and BEM1 mutant 
combinations, and also microscopically examined their vacuolar morphology. Loss of 
Cln3p or Bem1p leads to cellular and vacuolar enlargement and vacuolar fragmentation 
(Fig. 4.3). Conversely, cells expressing a stabilized form of Cln3p from the dominant 
gain-of-function CLN3-2D allele are smaller overall (Cross, 1988), and their vacuolar 
compartment is also smaller (see Fig. 4.3A and CHAPTER II). However, the CLN3-2D 
allele was unable to reduce cell and vacuole size in the absence of Bem1p (Fig. 4.3A). 
Furthermore, combined loss of Bem1p and Cln3p did not lead to an additive cellular or  
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Figure 4.3. Cln3p requires Bem1p to affect cell and vacuole size and vacuolar morphology. A, The 
relative vacuole size of the indicated strains (all in the diploid BY4743 background) was measured as in 
Fig. 2, and cell size was measured with a channelyzer. The average and standard deviation from four 
independent measurements in each case is shown. The indicated strains were also stained with FM4-64 to 
observe their vacuolar morphology by fluorescence microscopy. The percent of cells with vacuolar 
fragmentation and the number of cells scored in each case (n) is shown. B, The indicated parameters were 
measured as in A, using the strains shown (in the haploid BY4741 background). C, The DNA content of 
the indicated strains (in the diploid BY4743 background) was measured by flow cytometry. The number of 
cells is shown on the y-axis, and the x-axis indicates fluorescence. The percentage of budded cells (%B) is 
also shown. 
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vacuolar enlargement or vacuolar fragmentation (Fig. 4.3B). These results are consistent 
with the idea that Bem1p is required for Cln3p’s effects on cell and vacuole size, and 
that Bem1p and Cln3p do not affect vacuolar biogenesis through separate independent 
pathways. 
 Since Bem1p was required for Cln3p’s effects on cell and vacuole size (Fig. 
4.3A), we then evaluated cell cycle progression in bem1Δ CLN3-2D cells. In synthetic 
complete media at 30°C the population doubling times of bem1Δ and bem1Δ CLN3-2D 
cells were similar to each other (~200 min), but much slower than wild-type cells (~90 
min). The percentage of budded cells (budding index) was similar in bem1Δ and bem1Δ 
CLN3-2D cell populations (Fig. 4.3C). However, based on DNA content analysis by flow 
cytometry, it appears that bem1Δ cells carrying the CLN3-2D allele have a shorter G1 
phase (Fig. 4.3C). Thus, the CLN3-2D allele still accelerated initiation of DNA 
replication in bem1Δ cells, even though the cell and vacuolar size of these cells did not 
decrease. The irregular DNA content profiles of bem1Δ cells (Fig. 4.3C) might be due to 
aneuploidy, which has been previously reported to result from the bud emergence defect 
of bem1Δ cells (Bender and Pringle, 1991). 
 
Bem1p is phosphorylated in a Cdk-dependent manner 
It was mentioned in an earlier report that Bem1p might be a phosphoprotein, because 
phosphatase treatment leads to faster migration of Bem1p during SDS-PAGE (Leeuw et 
al., 1995). Indeed, immunoprecipitated TAP-tagged Bem1p migrated faster upon 
phosphatase treatment (Fig. 4.4A). Bem1p has four potential Cdk phosphorylation sites: 
two [ST]-P-X-[KR] sites at Thr-51 and Ser-72, and two [ST]-P sites at Thr-26 and Ser- 
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Figure 4.4. Bem1p is phosphorylated in a Cdk-dependent manner. A, Schematic of the TAP-tagged 
Bem1p. Bem1p-TAP was isolated from cells carrying a chromosomal TAP-tagged BEM1 copy (BEM1-
TAP, strain 7499374, see Table 2.1) by immunoprecipitation using IgG, and treated with calf intestinal 
phosphatase (CIP) as indicated. The samples were then processed for SDS-PAGE and immunobloting with 
the PAP reagent. B, Bem1p-TAP was isolated by tandem immunoprecipitations using IgG and Calmodulin 
beads. The IgG-immunoprecipitated material was treated with TEV protease as indicated, before 
immunoprecipitations with calmodulin beads. Immunobloting was done using the indicated antibodies. C, 
The immunoprecipitated samples from Bem1p-TAP cell extracts were treated as in B, and in addition with 
λ-phosphatase (λ-PPase) and phosphatase inhibitor (PPase-[I]) as indicated. The antibodies used for 
immunobloting are shown on the right, and the relative ratios of the signal intensities are shown at the 
bottom. D, The samples were processed as in C, but instead of phosphatase treatment, they were incubated 
with cytosolic extracts prepared from cells of the indicated genotype (200 µl in each case, containing 0.75 
mg of total protein). Before addition to the immunoprecipitated Bem1p, the extracts were pre-cleared on 
calmodulin beads. E, Extracts from CDC28+ and cdc28-as1 cells carrying cMyc-tagged Bem1p on a low 
copy plasmid (plasmid pDLB2226; see Table 2.2) were prepared using a urea extraction buffer and 
analyzed by SDS PAGE and immunoblotting with an anti-Myc antibody. The cells were treated with 
DMSO alone or 1 NM-PP1 (at 5 µM) for the indicated times. F, Vacuole fusion activity using cytosol 
from cdc28-as1 cells. DMSO alone or 1 NM-PP1 (at 5 µM for 15 min) was added as indicated. Fusion was 
evaluated colorimetrically and the average and standard deviation of the relative fusion activities from at 
least three independent experiments is shown. G, Extracts from cells of the indicated genotype (in the 
haploid BY4741 background) carrying cMyc-tagged Bem1p on a low copy plasmid (plasmid pDLB2226; 
see Table 2.2) were analyzed as in E. The same blot was sequentially processed first with an anti-Myc 
antibody and then with an anti-Pgk1p antibody. H, Extracts from synchronous cultures of wild-type 
haploid BY4741 cells carrying cMyc-tagged Bem1p on a low copy plasmid were obtained after release 
from a nocodazole block (used at 15 µg/ml for 4 hrs) at the indicated time points, and analyzed as in G. 
The corresponding percentage of budded cells in each case is shown at the bottom. Logarithmically 
growing cells (log) and cells that do not carry a cMyc-tagged copy of Bem1p (untagged) were also 
included in the analysis. 
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60, respectively. As a first step towards establishing possible Cdk-mediated 
phosphorylation events, we asked whether an antibody directed against phosphorylated 
[ST]-P recognized Bem1p immunoprecipitated from cell extracts. From these cell 
extracts, we sequentially immunoprecipitated Bem1p-TAP using IgG and Calmodulin 
beads (Fig. 4.4B). The immunoprecipitated protein was readily recognized by the PAP 
reagent, via the protein A domain (Fig. 4.4B). To use the anti phospho [ST]-P antibody, 
after immunoprecipitations with IgG beads, we cleaved the immunoprecipitated product 
with TEV protease to remove the protein A part of the TAP epitope. Immunoblotting 
with the anti phospho [ST]-P antibody recognized the cleaved Bem1p-CBP (which now 
lacks the protein A part of the TAP tag) (Fig. 4.4B). Recognition by the anti phospho 
[ST]-P antibody was phosphorylation-dependent, because the signal was significantly 
reduced after treatment with phosphatase (Fig. 4.4C). When normalized for Bem1p 
levels using an antibody that recognizes the remaining part of the TAP tag after TEV 
cleavage, treatment with phosphatase removed >70% of the signal (Fig. 4.4C, bottom). 
Furthermore, the Bem1p-associated phospho [ST]-P signal was about two times more 
intense when the immunoprecipitated product was incubated with extracts from cells 
carrying the CLN3-2D allele compared to cln3Δ extracts (Fig. 4.4D). 
 To further evaluate whether Cdc28p activity contributes to Bem1p 
phosphorylation, we used cdc28-as1 cells, which express an engineered version of 
Cdc28p that is inhibited by the ATP analog 1NM-PP1 (Bishop et al., 2000). These cells 
were then transformed with a low-copy centromeric plasmid carrying cMyc-tagged 
Bem1p (Irazoqui et al., 2003). Upon treatment with the inhibitory drug, the mobility of 
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Myc-tagged Bem1p increased on SDS-PAGE, consistent with dephosphorylation (Fig. 
4.4E). No such effects were seen upon treatment with DMSO or in the isogenic strain 
that does not carry the engineered cdc28-as1 allele (Fig. 4.4E). We had previously 
reported that shifting temperature-sensitive cdc28-1 cells to their non-permissive 
temperature led to vacuolar fragmentation (CHAPTER II). To further confirm that 
Cdc28p-associated kinase activity is required for vacuole homotypic fusion, we 
performed the in vitro fusion reaction using cytosol from cdc28-as1 cells, and we found 
that upon treatment with the inhibitory drug, fusion activity was reduced to ~40% of the 
activity when DMSO alone was added (Fig. 4.4F). Together, all of the above results 
support the hypothesis that Bem1p is phosphorylated in a Cdc28p-dependent manner in 
vivo. 
 We then examined the electrophoretic mobility of cMyc-tagged Bem1p in cells 
lacking mitotic or G1 cyclins (Fig. 4.4G). There was a slight mobility increase in cells 
lacking Cln3p (Fig. 4.4G; compare the cln3Δ and clb1Δ lanes that are equally loaded 
and electrophoresed next to each other; and see also Fig. 3.6, for related evidence). 
Finally, the electrophoretic mobility of Bem1p does not vary significantly during the cell 
cycle in synchronous cultures (Fig. 4.4H), but this perhaps is not surprising given that 
Cln3p/Cdc28p activity also does not oscillate during the cell cycle (Tyers et al., 1993; 
Tyers et al., 1992). 
 
  
81  
 
 
 
Ser72 is critical for Bem1p’s role in vacuolar homeostasis 
We then examined whether the Bem1p potential Cdk phosphorylation sites are 
conserved in other Saccharomyces species (Cliften et al., 2003; Kellis et al., 2003) and 
in Candida species for which genome information is available (Fig. 4.5A). Not 
surprisingly, all the sites are conserved in the sensu stricto Saccharomyces species (S. 
mikatae, S. kudriavzevii, S. paradoxus and S. bayanus). S. castellii is a more distantly 
related sensu lato Saccharomyces species, and alignment of Bem1p to its ortholog in this 
species is likely to be more useful (Cliften et al., 2003). In S. castellii only positions 26 
and 72 are conserved, while in the two Candida species positions 51 and 72 are 
conserved (Fig. 4.5A). The extreme N-terminus of the C. albicans Bem1p does not show 
significant conservation with the S. cerevisiae Bem1p, and the highlighted position may 
not correspond to Ser51. Overall, the only conserved site in all of these cases is Ser72 
(Fig. 4.5A), which is a preferred [ST]-P-X-[KR] Cdk consensus site. Ser72 also 
represents the first amino acid residue of the SH3-1 domain, which spans from position 
72 to 132, based on PROSITE software predictions (Gattiker et al., 2002). 
To test whether position 72 might be targeted for Cdk-mediated phosphorylation, 
we replaced Ser72 to Ala (to abolish phosphorylation) or Asp (to mimic 
phosphorylation) and evaluated the vacuolar morphology of bem1Δ or cln3Δ cells 
expressing these Bem1p mutants from low-copy plasmids as C- terminal cMyc fusions 
(Fig. 4.5B). The S72A and S72D mutants were expressed at levels similar to the wild- 
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Figure 4.5. Ser at position 72 in Bem1p is critical for vacuolar morphology. A, Bem1p amino acid 
sequences (positions 24-75) in Saccharomyces and Candida species. The numbering on top refers to S. 
cerevisiae Bem1p. The amino acids putatively targeted for Cdk-dependent phosphorylation are shown in 
bold, and the conserved Ser at position 72 is bracketed in red. B, Homozygous diploid WT, bem1Δ or 
cln3Δ cells (BY4743 background) were transformed with the low-copy empty vector, wild-type or mutant 
cMyc-tagged Bem1p as indicated. The transformants were then stained with FM4-64 to observe their 
vacuolar morphology by fluorescence microscopy. The percent of cells with vacuolar fragmentation and 
the number of cells scored in each case (n) is shown. Where indicated, the P value associated with a x2 
significance test is shown. C, Representative photographs of the indicated strains from B. The arrow 
indicates an example of vacuolar fragmentation. D, Homozygous diploid bem1Δ cells (BY4743 
background) carrying the CLN3-2D allele on a low copy plasmid were also transformed with the low copy 
wild-type or mutant cMyc-tagged Bem1p as indicated. Vacuolar morphology was evaluated as in B, 
above. E, Fusion reactions were performed as described in Materials and Methods, using cytosol from 
cells lacking both CLN3 and BEM1 (strain SMY01; Table 2.1) and recombinant proteins from bacteria as 
indicated. The average of the relative activities from two independent experiments is shown in each case. 
The data from the two experiments had a Pearson correlation value of 0.82, and a paired two-sample t-test 
value of 0.009. 
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type cMyc-tagged Bem1p, and their sub-cellular localization was indistinguishable from 
wild-type (data not shown). We noticed that introduction of the otherwise wild-type 
cMyc-tagged Bem1p on a low-copy centromeric plasmid only partially suppressed the 
vacuolar fragmentation of bem1Δ cells (Fig. 4.5B). The plasmid is clearly functional 
because it does suppress the bud emergence defect of bem1Δ cells {see below and 
(Irazoqui et al., 2003)}. The lack of strong suppression of the vacuolar fragmentation 
might be due to the relative under-expression of cMyc-tagged Bem1p from this plasmid 
compared to endogenous levels (Irazoqui et al., 2003). Consistent with this 
interpretation, cMyc-tagged Bem1p expressed from a high-copy (2µ) plasmid at levels 
no more than 2-fold higher compared to endogenous Bem1p (Irazoqui et al., 2003), 
showed strong suppression of the vacuolar fragmentation of bem1Δ cells (see below). 
Nonetheless, it is important to note that the fact that wild-type cMyc-tagged 
Bem1p from a low-copy plasmid only partially suppressed vacuolar fragmentation 
conveniently allows one to evaluate the effects of the S72D substitution even in bem1Δ 
(but CLN3+) cells. It was clear that S72D Bem1p suppressed vacuolar fragmentation 
better than wild-type Bem1p and, conversely, the S72A Bem1p mutant did not suppress 
at all the vacuolar fragmentation of bem1Δ cells (Fig. 4.5B,C). Because the S72A mutant 
is functional in bud emergence (see below), the lack of suppression in vacuolar 
fragmentation is unlikely to be due to the production of a non-functional unfolded 
protein. Finally, introduction of the S72D, but not the S72A, Bem1p mutant in cln3Δ 
cells also significantly suppressed their vacuolar fragmentation (Fig. 4.5B,C). 
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To further test the role of Ser72, we over-expressed Cln3p in cells carrying wild-
type or Ser72 Bem1p mutants (Fig. 4.5D). We found that cells carrying both the CLN3-
2D and BEM1-S72A alleles had fragmented vacuolar morphology (Fig. 4.5D). Thus, the 
S72A substitution blocks the ability of Cln3p to promote vacuole fusion in vivo. We then 
performed in vitro fusion reactions using cytosol from cells lacking both Cln3p and 
Bem1p, supplemented with various combinations of recombinant Cln3p, Bem1p, 
Bem1p-S72A, and Bem1p-S72D (Fig. 4.5E). The highest activity was observed upon 
addition of Bem1p-S72D with or without Cln3p, and the lowest upon addition of 
Bem1p-S72A. Also, addition of Cln3p alone or with Bem1p-S72A did not increase 
fusion activity (Fig. 4.5E). Therefore, these in vitro results completely support our in 
vivo evidence that Cln3p requires Bem1p to promote fusion. Furthermore, the S72A 
substitution in Bem1p blocks fusion, while the S72D mutation promotes it. Interestingly, 
addition of wild-type Bem1p also increased fusion activity in the absence of Cln3p, 
albeit not to the same level as Bem1p-S72D. Thus, it is possible that in the absence of 
Cln3p, when large amounts of exogenous Bem1p are added, Bem1p can still be modified 
in these extracts perhaps by other cyclin/Cdk complexes. Overall, our results from the in 
vitro fusion assays are in very good agreement with our in vivo evidence, and suggest 
that Cln3p and Bem1p play direct roles in vacuole fusion, with Bem1p acting 
downstream of Cln3p. 
Overall, these results strongly support the notion that the conserved Ser at 
position 72 in the first SH3 domain of Bem1p might be targeted for Cdk-mediated 
phosphorylation, and that the phosphorylated form promotes vacuolar homotypic fusion. 
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It is possible that the other sites may also be phosphorylated. However, because the 
S72D mutant significantly suppressed the vacuolar fragmentation of cln3Δ and bem1Δ 
cells in vivo and in vitro, while the S72A mutant did not, it is reasonable to conclude that 
even if additional sites are phosphorylated, phosphorylation of Ser72 has the most 
significant biological consequences for vacuolar biogenesis. 
 Since the electrophoretic mobility shift of Bem1p using SDS-PAGE was not very 
pronounced in the absence of Cln3p (Figs. 4.4G and 4.6B), we used two-dimensional gel 
electrophoresis to better resolve putative Bem1p isoforms (Fig. 4.6A). Indeed, an acidic 
isoform present in wild-type Bem1p (Fig. 4.6A, top panel) was absent in cells lacking 
Cln3p (Fig. 4.6A, middle panel), or in cells carrying Bem1p-S72A (Fig. 4.6A, bottom 
panel). We also noticed that Bem1p-S72A migrated slightly faster than wild-type Bem1p 
in standard one-dimensional SDS-PAGE (Fig. 4.6B). Together, these results strongly 
suggest that Bem1p is phosphorylated at Ser72 in a Cln3p-dependent manner in vivo. 
 Finally, we examined whether Bem1p expressed in bacteria could be 
phosphorylated in vitro. For this experiment we over-expressed CLN3 from a high-copy 
plasmid carrying epitope-tagged CLN3 under the control of a galactose-inducible 
promoter. It has been previously shown that over-expression of Cln3p allows for the 
recovery of detectable Cln3p-associated kinase activity against histone H1, and that most 
of that activity is Cdc28p-dependent (Tyers et al., 1993; Tyers et al., 1992). Indeed, the 
immunoprecipitated Cln3p had associated kinase activity against recombinant Bem1p, 
albeit to significantly lower levels compared to histone H1 (Fig. 4.6C). We also 
performed similar reactions using commercially available preparations of human  
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Figure 4.6. Gel electrophoresis analysis of Bem1p isoforms. A, Resolution of Bem1p isoforms by 2D gel 
electrophoresis. Extracts from cells of the indicated CLN3 genotype were transformed with the low copy 
wild-type or mutant cMyc-tagged Bem1p as indicated, subjected to 2D gel electrophoresis, and 
immunoblotting with an anti-Myc antibody as described in the Materials and Methods. A degradation 
product is indicated by an asterisk (*). A broken line circles the location of the acidic full-length isoform 
absent from the two lower panels. B, The samples from A were also analyzed by standard one-dimensional 
SDS-PAGE and immunoblotting. C, Phosphorylation of Bem1p in vitro. (Top) autoradiogram of kinase 
reactions using recombinant Bem1p as a substrate and commercial preparations of human Cdk/cyclin 
complexes and Cln3p-associated kinase activity from yeast cells, as indicated. Exposure time was 10 days. 
(Bottom) autoradiogram of kinase reactions using histone H1 as a substrate and the same kinase 
preparations as in the top panel. Exposure time was 4 hrs. 
 
 
  
88  
 
 
 
Cdc2/cyclinB and Cdk2/cyclinA complexes. Surprisingly, Cdc2/cyclinB apparently 
phosphorylated Bem1p (Fig. 4.6C). Whether this reflects “background” non-specific 
levels of activity of this preparation is unclear at this point. Note that although the Cdc2 
signal appears stronger than the signal from Cln3p (Fig. 4.6C), the commercial Cdc2 
preparation we used was much more active against histone H1 than the Cln3p-associated 
activity we obtained from yeast cells. 
 
Opposing role of Ser72 in bud emergence 
Since Bem1p was originally identified for its role in bud emergence (Bender and 
Pringle, 1991), we next examined whether our Bem1p Ser72 mutants have phenotypes 
associated with bud emergence. To quantify the bud emergence defect we measured the 
frequency of unbudded cells containing spindles. The S72A mutant was fully functional 
in bud emergence (Fig. 4.7), in contrast to its total lack of complementing activity in 
vacuole fusion (Fig. 4.5). Interestingly, the S72D substitution did not fully complement 
the bud emergence defect of bem1Δ cells (Fig. 4.7). Thus, while phosphorylation of 
Ser72 promotes vacuole fusion, it is not required for and it might even negatively affect 
bud emergence. 
 
Over-expression of Cdc42p or Cdc24p suppresses the vacuolar fragmentation of cln3Δ 
cells 
We next examined whether Cln3p’s requirement for vacuolar homotypic fusion might 
reflect perturbations of Cdc42p activity, since Bem1p is a well-established regulator of  
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Figure 4.7. Rescue of bud emergence defect in bem1Δ cells by different BEM1 alleles. Homozygous 
diploid WT or bem1Δ cells (BY4743 background) were transformed with the low copy empty vector, 
wild-type or mutant cMyc-tagged Bem1p as indicated. The cells were grown at 37 °C, fixed and processed 
for immunofluorescence to visualize tubulin. A, The percent of unbudded cells with spindles and the 
number of cells scored in each case (n) is shown. Where indicated, the P value associated with a χ2 
significance test is shown. B, Representative photographs of the indicated strains from A. Examples of 
unbudded cells with spindles are outlined. 
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Cdc42p, and Cdc42p is also required for the docking step of vacuolar homotypic fusion 
(Eitzen et al., 2001; Muller et al., 2001). To perhaps bypass the requirement for Cln3p, 
we activated the Cdc42p GTPase cycle by over-expressing wild-type CDC42, or its 
exchange factor CDC24, in cln3Δ cells and evaluated their vacuolar morphology. 
Remarkably, over-expression of CDC42 or CDC24 completely suppressed the 
fragmented vacuolar morphology of cln3Δ cells (Fig. 4.8A,B). On the other hand, over-
expression of CDC42 did not significantly suppress the vacuolar fragmentation of 
bem1Δ cells (Fig. 4.8B). CDC24 over-expression weakly suppressed the vacuolar 
fragmentation in bem1Δ cells (Fig. 4.8B). Overall, over-expression of Cdc42p, in the 
presence of Bem1p, is sufficient to bypass the requirement for Cln3p in vacuole fusion. 
Furthermore, in the in vitro fusion assay addition of Cdc42p did not rescue the fusion 
defect of bem1Δ cytosolic extracts (Fig. 4.8C), suggesting again that Bem1p is required 
for Cdc42p to promote fusion. Interestingly, when the extracts were supplemented with 
Bem1p-S72A together with Cdc42p there was an increase in fusion activity (~60%; Fig. 
4.8C), but not to the same extent as when the extracts were supplemented with Bem1p-
S72D (see Fig. 4.5E). 
 We next examined several other Bem1p amino acid substitutions at positions that 
are important for Bem1p’s biological roles (Irazoqui et al., 2003), for their ability to 
suppress vacuolar fragmentation of bem1Δ cells (Fig. 4.8D). For example, a P208L 
substitution affects interactions with various effectors and scaffolds; P355A interferes 
with a postulated conformational change of Bem1p; R369A inhibits interactions with 
phosphoinositides; and K482A affects interaction with Cdc24p (Irazoqui et al., 2003).  
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Figure 4.8. CDC42 or CDC24 over-expression suppresses the vacuolar fragmentation of cln3Δ cells. A, 
Diploid cln3Δ cells (BY4743 background) were transformed with high copy plasmids as indicated. The 
transformants were then stained with FM4-64 to observe their vacuolar morphology and photographed 
through phase optics (top panels) and by fluorescence (bottom panels). B, The same analysis as in A was 
also done for bem1Δ and WT cells, and the percent of cells with vacuolar fragmentation and the number of 
cells scored in each case (n) is shown. Where indicated, the P value associated with a χ2 significance test 
is shown. C, Fusion reactions were performed as described in Materials and Methods, using cytosol from 
bem1Δ cells and recombinant proteins from bacteria as indicated. Fusion was evaluated colorimetrically 
and the average and standard deviation of the relative fusion activities from at least three independent 
experiments is shown. D, Homozygous diploid bem1Δ cells (BY4743 background) were transformed with 
the empty high copy vector, or carrying wild-type or mutant cMyc-tagged Bem1p as indicated. The 
transformants were then stained with FM4-64 to observe their vacuolar morphology by fluorescence 
microscopy. The percent of cells with vacuolar fragmentation and the number of cells scored in each case 
(n) is shown. Where indicated, the P value associated with a χ2 significance test is shown. E, Cells lacking 
Bem1p are not defective in vacuolar segregation. Exponentially growing cells of the indicated genotype 
were transferred in medium containing FM4-64 for 1 h, washed, re-suspended in fresh medium and 
allowed to grow for another 4h before they were examined microscopically. The number of cells examined 
is shown in parentheses. The scored cells had a bud diameter less or equal to 0.4 of the mother cell’s 
diameter. The percentage of cells with the indicated vacuolar morphology is shown. 
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The R369A substitution did not have any effect (Fig. 4.8D), suggesting perhaps that 
lipid interactions are not important for Bem1p’s function in vacuolar homotypic fusion. 
To varying degrees, the other Bem1p mutants also significantly suppressed vacuolar 
fragmentation of bem1Δ cells (Fig. 4.8D). Notably, the weakest suppression, albeit still 
significant, was observed with the P208L substitution (Fig. 4.8D), which affects protein-
protein interactions through the SH3-2 domain (Irazoqui et al., 2003). 
 Finally, since the actin cytoskeleton plays a major role in vesicle transport in the 
bud and vacuole inheritance (Pruyne et al., 2004; Weisman, 2003), we decided to 
evaluate vacuolar segregation in bem1Δ cells. When we followed the “old” vacuolar 
compartment synthesized in previous cell divisions, we found that bem1Δ and wild-type 
cells equally distribute their vacuoles between the mother and the bud (Fig. 4.8E), unlike 
cln3Δ cells which have a weak but measurable defect (Fig. 3.8E and CHAPTER II). 
Furthermore, over-expression of CDC42 did not alter the vacuolar segregation of cln3Δ 
cells (data not shown). Overall, these results suggest that it is unlikely that the 
mechanism we describe here linking Cln3p and Bem1p significantly affects vacuole 
segregation. 
 
Discussion 
 
In this study we present experiments that link the G1 cyclin Cln3p with vacuole fusion, 
through Bem1p and the Cdc42p GTPase. We discuss our findings in the context of the 
known roles of these proteins and how they might affect vacuolar homeostasis. 
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 We were initially led to Bem1p because bem1Δ cells are large and their vacuolar 
compartment is also enlarged and fragmented, similar to the situation in cln3Δ cells (Fig. 
4.2 and CHAPTER II). The experiments we report here suggest that Bem1p is 
phosphorylated in a Cdk-dependent manner. The biological significance of Ser72 
phosphorylation is underscored by the fact that a substitution to Asp that probably 
mimics phosphorylation suppresses vacuolar fragmentation, while an Ala substitution 
does not (Fig. 4.5). Our data strongly point to the link between Cln3p and modification 
of Ser72 (Fig. 4.6). In vitro, however, it appears that multiple Cdk complexes can 
phosphorylate Bem1p. Addition of Bem1p from bacteria can still promote vacuole 
fusion in vitro, in the absence of Cln3p (Fig. 4.5E), suggesting that other cyclin/Cdk 
complexes might also be able to phosphorylate this exogenous pool of Bem1p. 
Furthermore, Clb2p/Cdc28p was previously shown to phosphorylate Bem1p (Ubersax et 
al., 2003) in vitro. This result was further extended in a follow-up study, where Loog and 
Morgan found that Clb5p/Cdc28p and Clb2p/Cdc28p phosphorylated Bem1p with equal 
efficiency (Loog and Morgan, 2005). Nonetheless, in living cells Cln3p certainly plays a 
unique role in vacuolar biogenesis because loss of any other cyclin does not lead to 
vacuolar fragmentation (CHAPTER II; Seeley et al., 2002).  
Cln3p abundance and activity does not significantly oscillate in the cell cycle 
(Tyers et al., 1993; Tyers et al., 1992), and the same seems to be true for the 
electrophoretic mobility of Bem1p in synchronously cycling cells (Fig. 4.4H). While it is 
thought that overall vacuolar biogenesis is the result of reciprocal control between 
vacuole fusion and fission (Peters et al., 2004), there is no evidence that either of these 
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processes oscillate in the cell cycle. Vacuolar inheritance is thought to be coordinated 
with the cell cycle and we have previously reported that loss of Cln3p leads to mild 
defects in vacuolar segregation (CHAPTER II and see also Fig. 4.8E), but there are no 
such defects in bem1Δ cells (Fig. 4.8E). Thus, although the mechanism we describe here 
linking Cln3p with Bem1p certainly impacts on the “steady-state” overall vacuolar 
homeostasis, it may not necessarily impart an oscillatory feature to it. 
On the other hand, Cln3p’s vacuolar roles strongly affect the cell size phenotypes 
associated with CLN3 mutations (see Fig. 4.3 and CHAPTER II). As we have discussed 
previously (CHAPTER II), this does not extend to all cell size mutants. Vacuolar 
enlargement is usually accompanied by cellular enlargement (Efe et al., 2005) but the 
converse is not necessarily true and not all large cell size mutants have large vacuoles. 
This is exemplified in double mutant cln1,2Δ cells, which are large overall although they 
have small vacuoles (CHAPTER II). A general correlation between vacuolar 
fragmentation and cell size also does not seem to exist (Fig. 4.2A). Nonetheless, our data 
also show that in bem1Δ cells CLN3 over-expression accelerated initiation of DNA 
replication (Fig. 4.3C), without a concomitant reduction in cell size (Fig. 4.3A). All 
these observations suggest that Cln3p’s role in vacuole fusion is separate from and 
probably does not impact on the other function of Cln3p in accelerating initiation of 
DNA replication. 
 How might cyclin-dependent phosphorylation of Bem1p impact on vacuole 
fusion? Cdc42p is involved in actin dynamics (Etienne-Manneville, 2004; Irazoqui and 
Lew, 2004) and vacuole fusion (Eitzen et al., 2001; Muller et al., 2001). Importantly, the 
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temporal requirement of Cln3p or Cdc42p for fusion appears to be similar. Loss of either 
Cln3p or Cdc42p leads to vacuolar fragmentation, but once the docking step of fusion is 
completed neither Cln3p (Fig. 4.1) nor Cdc42p (Eitzen et al., 2001; Muller et al., 2001) 
are required anymore for fusion. While it is clear that non-cytoskeletal actin is found on 
the surface of vacuoles and remodeling of this actin pool is required for vacuole fusion 
(Eitzen et al., 2002), it is not known how it contributes to fusion. This requirement is 
distinct from the actin cytoskeleton-dependent processes of vacuole segregation (Pruyne 
et al., 2004; Weisman, 2003). Since we find no evidence for a defect in vacuolar 
segregation in bem1Δ cells (Fig. 4.8D), there is no reason to think that the cyclin-
dependent phosphorylation of Bem1p we describe here affects this process. 
Consequently, our data placing Bem1p downstream of Cln3p (Figs. 4.3,4.5), and the 
ability of Cdc42p to suppress vacuole fragmentation in cln3Δ cells (Fig. 4.8), probably 
reflect the non-cytoskeletal role of actin for vacuole fusion that has been proposed by the 
Wickner and Mayer labs (Eitzen et al., 2001; Eitzen et al., 2002; Muller et al., 2001). 
Organelle bound actin could also act as a fusion barrier, which must transiently 
disassemble for vesicles to dock, while later promoting actin assembly is thought to 
somehow help the docked vesicles to finally fuse (Eitzen, 2003). Based on chemical 
inhibition experiments, it appears that the actin depolymerizing drug latrunculin B 
inhibits the last fusion step of vacuole homotypic fusion (Eitzen et al., 2001). 
Interestingly, the F-actin binding and stabilizing drug jasplakinolide inhibited the 
docking step of fusion only, and not the last latrunculin B-sensitive step (Eitzen et al., 
2001). Given that Cln3p (Fig. 4.1) and Cdc42p (Eitzen et al., 2001; Muller et al., 2001) 
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are not required after the docking step of fusion; the fact that Ser72 of Bem1p has 
distinct and even opposing roles in vacuole fusion vs. bud emergence (Figs. 4.5 and 4.7); 
and the fact that other Bem1p mutants that affect bud emergence do not affect vacuole 
fusion (Fig. 4.8), it is possible that the effects we are observing reflect the “actin as a 
barrier” model of fusion (Eitzen, 2003). 
 Does cyclin-dependent phosphorylation of Bem1p affect other Bem1p-regulated 
processes? The S72A substitution is incapable of suppressing vacuolar fragmentation in 
bem1Δ cells, but it is still fully active in bud emergence (Figs. 4.5 and 4.7). On the other 
hand, the S72D substitution fully suppresses vacuole fragmentation but it only partially 
suppresses bud emergence (Figs. 4.5 and 4.7). These results suggest that Bem1p has 
distinct roles in bud emergence and vacuole fusion. While presumably locking Ser72 to 
the phosphorylated state (in the S72D mutant) suffices to suppress vacuolar 
fragmentation (Fig. 4.5), it might adversely affect bud emergence (Fig. 4.7). 
The notion that Bem1p’s roles in vacuole fusion and bud emergence may be 
distinct is also suggested by the fact that other Bem1p mutants (for example the K482A 
mutant) that were shown to be unable to suppress bud emergence defects (Irazoqui et al., 
2003), retain full complementing ability in vacuole fusion (Fig. 4.8D). Even the P208L 
mutant, which cannot complement bud emergence (Irazoqui et al., 2003), partially 
suppressed vacuolar fragmentation (Fig. 4.8D). The P208L mutant affects interactions 
between the SH3-2 domain of Bem1p with various effectors, including the Cla4p kinase. 
Interestingly, loss of Cla4p leads to vacuolar fragmentation (Seeley et al., 2002), and it is 
possible that interactions mediated by the SH3-2 domain of Bem1p might be important 
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for vacuole fusion, explaining the incomplete suppression of vacuolar fragmentation we 
got from the P208L mutant (Fig. 4.8D). 
In any case, since the actin remodeling necessary for vacuole fusion is not the 
same as the rearrangement of the actin cytoskeleton that takes place during bud 
emergence, probably identical mechanisms/effectors do not operate in both processes. It 
should also be noted that while Cln1p and Cln2p have established roles in bud 
emergence (Bose et al., 2001; Gulli et al., 2000; Moffat and Andrews, 2004), they do not 
affect vacuole fusion (CHAPTER II). Finally, although there are no known protein-
protein interactions mediated by the SH3-1 domain of Bem1p, it is possible that Ser72 
might impact on vacuole fusion through interactions with effectors that have specific 
roles in fusion. Given the scaffold role of Bem1p and the fact that addition of Cdc42p in 
the presence of the Bem1p-S72A mutant did not promote fusion as efficiently as the 
Bem1p-S72D mutant alone (compare Figs. 4.8C and 3.5E), it is possible that 
phosphorylation of Ser72 is important for some kind of protein-protein interactions that 
promote vacuole fusion. Future experiments need to address in full detail the 
mechanisms that account for the differences between Bem1p’s roles in vacuole fusion 
and bud emergence. 
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CHAPTER V 
SUMMARY AND PERSPECTIVES 
 
We found a novel role of Cln3p in vacuolar fusion and biogenesis independent of its 
well-established function in the activation of G1 transcription. Cln3p/Cdc28p directly 
regulates vacuolar homotypic fusion and vacuolar copy number by a post-translational 
mechanism. Overall vacuole size disproportionately increases in cln3Δ cells, which 
accounts for most of their cell size increase. 
 Furthermore, we identified a scaffold protein, Bem1p, as the target of 
Cln3p/Cdc28p in vacuolar fusion. Bem1p is required for the vacuolar function of Cln3p 
both in vivo and in vitro. Our results indicate that Ser72 on Bem1p is phosphorylated by 
Cdc28p in a Cln3p-dependent manner and that Cln3p’s vacuolar function is executed by 
the regulation of this phosphorylation. In contrary, bud emergence was promoted by an 
unphosphorylated Ser72 isoform but not by a phosphorylated Ser72 isoform. Over-
expression of Cdc42p GTPase bypasses the requirement of Cln3p for vacuolar 
homotypic fusion only in the presence of Bem1p, suggesting that the Ser 72 
phosphorylation by Cln3p/Cdc28p impacts on the regulation of Bem1p/Cdc42p-
dependent actin polymerization and as a result vacuolar homotypic fusion. 
 Our results are remarkable in several respects. First, they contain the first 
demonstration in yeast that a cell cycle regulator directly regulates an organelle’s 
membrane fusion. Second, they suggest that organelle biogenesis and membrane 
trafficking, rather than the conventional molecule-to molecule interactions, should be 
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taken into account to better understand cell size control. Third, they provide high 
resolution details of a molecular mechanism such that phosphorylation of a single amino 
acid on a protein is exclusively dependent on a specific cyclin in vivo. Fourth, they add 
an important, rare illustration to the currently brief list of examples of how Cdk-
dependent phosphorylation of a single amino acid on a protein gives rise to a distinct and 
significant biological consequence, as seen in the differential effect of Bem1p’s Ser72 
phosphorylation on vacuolar homotypic fusion versus bud emergence. 
 Actin polymerization is of fundamental importance in that it provides the 
structural basis of cytoskeleton and cell morphogenesis and motility, as well as it plays a 
role in vacuolar homotypic fusion and neural signaling. A further mechanistic study on 
how a single phosphorylation on Bem1p results in such a significant impingement on 
Cdc42p activity and actin polymerization will provide an important insight into these 
actin-involving processes. 
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